| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L IRF2BP2 NCOA3 KDM3A NCOA6 ABL1 PPRC1 NACA BCORL1 MAML1 MED14 BCL11A ACSS2 DCC BCL9 SRCAP SSBP3 ARID1A RXRB HIRA KMT2C ARID1B MAML3 THRAP3 CNOT2 MED13 ZNF541 RUNX1T1 CREBBP KMT2D TRIM28 TLE1 TLE3 SMARCA4 DOT1L TOX2 EP300 | 5.23e-17 | 562 | 244 | 37 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA3 NCOA6 ABL1 PPRC1 NACA MAML1 MED14 ACSS2 DCC BCL9 SRCAP SSBP3 ARID1A RXRB KMT2C ARID1B MAML3 THRAP3 MED13 CREBBP KMT2D TRIM28 SMARCA4 DOT1L TOX2 EP300 | 7.63e-16 | 303 | 244 | 27 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L IRF2BP2 NCOA3 KDM3A NCOA6 ABL1 RIPK1 PPRC1 NACA BCORL1 MAML1 MED14 BCL11A ACSS2 DCC BCL9 SRCAP SSBP3 ARID1A SPATA2 RXRB HIRA KMT2C WWC2 ARID1B FBXO4 MAML3 THRAP3 CNOT2 MED13 ZNF541 ANK2 RUNX1T1 CREBBP KMT2D SHANK2 TRIM28 TLE1 TLE3 SMARCA4 GAB3 AKAP13 DOT1L RIMS2 TOX2 EP300 | 1.10e-12 | 1160 | 244 | 46 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L IRF2BP2 NCOA3 KDM3A NCOA6 ABL1 RIPK1 PPRC1 NACA BCORL1 MAML1 MED14 BCL11A ACSS2 DCC BCL9 SRCAP SSBP3 ARID1A SPATA2 RXRB HIRA KMT2C WWC2 ARID1B FBXO4 BAG6 MAML3 THRAP3 CNOT2 MED13 ZNF541 ANK2 RUNX1T1 CREBBP KMT2D SHANK2 TRIM28 TLE1 TLE3 SMARCA4 GAB3 AKAP13 DOT1L RIMS2 TOX2 EP300 | 6.49e-11 | 1356 | 244 | 47 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA3 MAGEA6 NCOA3 KDM3A NCOA6 PPRC1 NACA GATA1 MED14 BCL11A ARID1A RXRB HIRA SATB1 FOXO4 TAF4 THRAP3 CNOT2 MED13 EBF4 PCLO SALL4 RUNX1T1 CREBBP EAF1 TLE1 SMARCA4 DOT1L TOX2 EP300 PROX1 | 3.41e-09 | 753 | 244 | 31 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MAGEA3 MAGEA6 NCOA3 KDM3A NCOA6 GATA1 MED14 BCL11A ARID1A RXRB HIRA SATB1 FOXO4 TAF4 THRAP3 MED13 EBF4 RUNX1T1 CREBBP TLE1 SMARCA4 DOT1L TOX2 EP300 PROX1 | 5.58e-08 | 582 | 244 | 25 | GO:0140297 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 KDM3A NCOA6 PATZ1 GATA1 ACSS2 ARID1A CIC RXRB HIRA ARID1B SATB1 SUPT5H FOXO4 EP400 CREBBP CREB3L1 TRIM33 TRIM28 TLE1 TP63 H1-3 SMARCA4 MBD5 TOX2 TCF7L1 EP300 | 4.15e-07 | 739 | 244 | 27 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA3 ZNF384 PATZ1 ZBTB22 ZNF189 GATA1 E2F7 KLF3 EVX1 ZNF395 BCL11A CIC RXRB TLX1 BBX SATB1 FOXO4 TET3 THRAP3 HOXB13 EBF4 NPAS2 ZNF577 SOX30 ZBTB4 SALL4 RELB RFX7 CREBBP CREB3L1 LHX1 NKX2-4 TP63 SMARCA4 ZFHX2 HSFX1 ZFHX3 TCF7L1 EP300 PROX1 | 1.18e-06 | 1459 | 244 | 40 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 1.97e-06 | 18 | 244 | 5 | GO:0042809 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF384 PATZ1 ZBTB22 ZNF189 GATA1 E2F7 KLF3 EVX1 ZNF395 BCL11A RXRB TLX1 SATB1 FOXO4 TET3 THRAP3 HOXB13 EBF4 NPAS2 ZNF577 SOX30 ZBTB4 SALL4 RELB RFX7 CREB3L1 LHX1 NKX2-4 TP63 SMARCA4 ZFHX2 HSFX1 ZFHX3 TCF7L1 EP300 PROX1 | 2.09e-06 | 1271 | 244 | 36 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF384 PATZ1 ZBTB22 ZNF189 GATA1 E2F7 KLF3 EVX1 ZNF395 BCL11A RXRB TLX1 SATB1 FOXO4 TET3 THRAP3 HOXB13 EBF4 NPAS2 ZNF577 SOX30 ZBTB4 SALL4 RELB RFX7 CREB3L1 NKX2-4 TP63 SMARCA4 ZFHX2 HSFX1 ZFHX3 TCF7L1 EP300 PROX1 | 3.42e-06 | 1244 | 244 | 35 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NCOA3 ZNF384 PATZ1 ZBTB22 ZNF189 GATA1 E2F7 KLF3 EVX1 ZNF395 BCL11A CIC RXRB TLX1 BBX SATB1 FOXO4 HOXB13 EBF4 NPAS2 ZNF577 SOX30 ZBTB4 TPRX2 SALL4 RELB RFX7 CREB3L1 LHX1 KMT2D NKX2-4 TP63 YLPM1 ZFHX2 HSFX1 ZFHX3 TCF7L1 PROX1 | 3.53e-06 | 1412 | 244 | 38 | GO:0000981 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 9.29e-06 | 61 | 244 | 7 | GO:0030374 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 KDM3A NCOA6 GATA1 MED14 ARID1A RXRB HIRA TAF4 THRAP3 MED13 CREBBP SMARCA4 DOT1L TOX2 EP300 PROX1 | 1.60e-05 | 417 | 244 | 17 | GO:0061629 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.69e-05 | 120 | 244 | 9 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | NCOA3 KDM3A NCOA6 MED14 ARID1A RXRB THRAP3 MED13 SMARCA4 EP300 PROX1 | 1.99e-05 | 187 | 244 | 11 | GO:0016922 |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 5.45e-05 | 34 | 244 | 5 | GO:0046966 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.11e-04 | 21 | 244 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | IRF2BP2 BCORL1 BCL11A HIRA ZNF541 RUNX1T1 CREBBP TRIM28 TLE1 TLE3 SMARCA4 | 1.25e-04 | 229 | 244 | 11 | GO:0003714 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.49e-04 | 2 | 244 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.49e-04 | 2 | 244 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA3 ZNF384 NCOA6 ABL1 RIPK1 LILRB2 GATA1 SH3BP1 DAB1 GJA1 SCAF1 ZFYVE9 MUC17 ATXN2 MICAL1 APBA1 DENND1A CREBBP SHANK2 TRIM28 TP63 RIMS2 INPP5J PROX1 | 1.94e-04 | 875 | 244 | 24 | GO:0019904 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.25e-04 | 25 | 244 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | p53 binding | 3.60e-04 | 77 | 244 | 6 | GO:0002039 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 3.82e-04 | 143 | 244 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.43e-04 | 3 | 244 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.74e-04 | 33 | 244 | 4 | GO:0050681 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.05e-03 | 37 | 244 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.06e-03 | 167 | 244 | 8 | GO:0031490 | |
| GeneOntologyMolecularFunction | structural molecule activity | OPTC POM121 PNPLA1 MUC17 ACAN NID1 MPZ HSPG2 ANK2 MRPS18B COL27A1 PCLO POM121L2 MAP7 POM121C CRYBA2 SHANK2 H1-3 NUP133 CTNND2 RIMS2 MUC6 | 1.43e-03 | 891 | 244 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.69e-03 | 42 | 244 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | ubiquitin-specific protease binding | 1.76e-03 | 20 | 244 | 3 | GO:1990381 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | PATZ1 E2F7 BCL11A SATB1 HOXB13 SOX30 ZBTB4 CREB3L1 YLPM1 ZFHX3 PROX1 | 2.02e-03 | 320 | 244 | 11 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA binding domain binding | 2.16e-03 | 6 | 244 | 2 | GO:0050692 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | PATZ1 E2F7 BCL11A SATB1 HOXB13 SOX30 ZBTB4 CREB3L1 YLPM1 ZFHX3 PROX1 | 2.33e-03 | 326 | 244 | 11 | GO:0001217 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L NCOA3 KDM3A ZNF384 NCOA6 ABL1 RIPK1 PPRC1 PATZ1 NACA GATA1 MAML1 MED14 E2F7 EVX1 ZNF395 BCL9 SSBP3 RXRB TLX1 KMT2C SUPT5H FOXO4 TAF4 TET3 MAML3 THRAP3 MED13 CAVIN2 EBF4 AGAP2 NPAS2 SOX30 AKNA SALL4 RELB RFX7 CREBBP CREB3L1 KMT2D EAF1 TP63 SMARCA4 ZFHX3 DOT1L SSBP4 TOX2 TCF7L1 EP300 PROX1 | 1.79e-12 | 1390 | 247 | 50 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RALGAPA1 MAGEA3 IRF2BP2 MAGEA6 PATZ1 NACA BCORL1 GATA1 E2F7 ZMYM2 KLF3 BCL11A ARID1A CIC HIRA WWC2 SATB1 SUPT5H SAP130 CNOT2 HOXB13 ZNF541 SOX30 ZBTB4 SALL4 RELB RUNX1T1 CREBBP CREB3L1 LHX1 TRIM33 TRIM28 TLE1 TLE3 TP63 YLPM1 H1-3 SMARCA4 ZFHX3 TCF7L1 EP300 PROX1 | 3.02e-08 | 1399 | 247 | 42 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RALGAPA1 MAGEA3 IRF2BP2 MAGEA6 PATZ1 NACA BCORL1 GATA1 E2F7 ZMYM2 KLF3 BCL11A ARID1A CIC HIRA WWC2 SATB1 SUPT5H SAP130 CNOT2 HOXB13 ZNF541 SOX30 ZBTB4 SALL4 RELB RUNX1T1 CREBBP CREB3L1 LHX1 TRIM33 TRIM28 TLE1 TLE3 TP63 YLPM1 H1-3 SMARCA4 ZFHX3 TCF7L1 EP300 PROX1 | 4.00e-08 | 1413 | 247 | 42 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | RALGAPA1 MAGEA3 IRF2BP2 MAGEA6 PATZ1 NACA BCORL1 GATA1 E2F7 KLF3 BCL11A ARID1A CIC WWC2 SATB1 SUPT5H SAP130 CNOT2 HOXB13 SOX30 ZBTB4 SALL4 CREBBP CREB3L1 TRIM33 TRIM28 TLE1 TP63 YLPM1 H1-3 SMARCA4 ZFHX3 EP300 PROX1 | 1.39e-07 | 1053 | 247 | 34 | GO:0000122 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | BCL9L NCOA3 KDM3A MED14 BCL9 ARID1A SAP130 CNOT2 SALL4 CREBBP TP63 SMARCA4 TCF7L1 PROX1 | 1.11e-06 | 237 | 247 | 14 | GO:0019827 |
| GeneOntologyBiologicalProcess | maintenance of cell number | BCL9L NCOA3 KDM3A MED14 BCL9 ARID1A SAP130 CNOT2 SALL4 CREBBP TP63 SMARCA4 TCF7L1 PROX1 | 1.42e-06 | 242 | 247 | 14 | GO:0098727 |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 4.30e-06 | 78 | 247 | 8 | GO:2000036 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | NCOA3 KDM3A PATZ1 SPATA31A7 GATA1 E2F7 SPATA2 SPATA31A6 SPATA31C1 RXRB GJA1 TMEM184A TAF4 BAG6 HOXB13 ZNF541 SCHIP1 SPATA31A3 SOX30 SPATA31C2 MAP7 SPATA31A5 LHX1 GORASP2 KMT2D SPATA31A1 ADGRG2 TRIM28 TLE3 TP63 SPAG17 PUM1 VPS13B | 1.30e-05 | 1235 | 247 | 33 | GO:0003006 |
| GeneOntologyBiologicalProcess | developmental growth | NCOA3 ABL1 NACA BCL11A DCC BCL9 RXRB GJA1 KMT2C WWC2 ATXN2 COL27A1 APBA1 PUM2 SALL4 MAP7 LHX1 KMT2D TRIM28 SMARCA4 AKAP13 TMEM108 MBD5 RIMS2 EP300 VPS13B PROX1 | 1.43e-05 | 911 | 247 | 27 | GO:0048589 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | NCOA3 KDM3A ARID1A RXRB CNOT2 KMT2D TP63 SMARCA4 AKAP13 EP300 | 1.82e-05 | 155 | 247 | 10 | GO:0043401 |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 NCOA6 ABL1 TMEM94 GATA1 E2F7 EVX1 SSBP3 ARID1A RXRB HIRA ACSL4 GJA1 BAG6 CNOT2 PRRC2B HSPG2 COL27A1 APBA1 APBA3 SALL4 ECE1 CREBBP LHX1 KMT2D TRIM28 TP63 KIAA1217 NUP133 SMARCA4 ASB2 TCF7L1 EP300 PHLDB2 PROX1 | 4.82e-05 | 1437 | 247 | 35 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA3 NCOA6 ABL1 GATA1 E2F7 EVX1 SSBP3 ARID1A RXRB ACSL4 GJA1 CNOT2 PRRC2B HSPG2 APBA1 APBA3 SALL4 ECE1 LHX1 KMT2D TRIM28 KIAA1217 NUP133 SMARCA4 EP300 PROX1 | 5.43e-05 | 929 | 247 | 26 | GO:0009792 |
| GeneOntologyBiologicalProcess | growth | NCOA3 ABL1 NACA BCL11A DCC BCL9 RXRB ACSL4 GJA1 KMT2C WWC2 ATXN2 HOXB13 COL27A1 APBA1 PUM2 SALL4 MAP7 SGK2 LHX1 KMT2D TRIM28 SMARCA4 AKAP13 TMEM108 MBD5 RIMS2 CSNK2A3 EP300 VPS13B PROX1 | 7.86e-05 | 1235 | 247 | 31 | GO:0040007 |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 8.09e-05 | 60 | 247 | 6 | GO:0021587 | |
| GeneOntologyBiologicalProcess | spermatogenesis | KDM3A PATZ1 SPATA31A7 SPATA2 SPATA31A6 SPATA31C1 GJA1 BAG6 ZNF541 SPATA31A3 SOX30 SPATA31C2 MAP7 SPATA31A5 GORASP2 SPATA31A1 ADGRG2 TLE3 TP63 SPAG17 PUM1 VPS13B | 9.52e-05 | 744 | 247 | 22 | GO:0007283 |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 1.16e-04 | 64 | 247 | 6 | GO:0021575 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 1.16e-04 | 64 | 247 | 6 | GO:0010171 | |
| GeneOntologyBiologicalProcess | male gamete generation | KDM3A PATZ1 SPATA31A7 SPATA2 SPATA31A6 SPATA31C1 GJA1 BAG6 ZNF541 SPATA31A3 SOX30 SPATA31C2 MAP7 SPATA31A5 GORASP2 SPATA31A1 ADGRG2 TLE3 TP63 SPAG17 PUM1 VPS13B | 1.34e-04 | 762 | 247 | 22 | GO:0048232 |
| GeneOntologyBiologicalProcess | regulation of anterior head development | 1.43e-04 | 2 | 247 | 2 | GO:2000742 | |
| GeneOntologyBiologicalProcess | positive regulation of anterior head development | 1.43e-04 | 2 | 247 | 2 | GO:2000744 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 1.91e-04 | 10 | 247 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 1.91e-04 | 10 | 247 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.38e-04 | 136 | 247 | 8 | GO:0030518 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA3 NCOA6 ABL1 GATA1 E2F7 SSBP3 ARID1A RXRB GJA1 CNOT2 PRRC2B HSPG2 APBA1 APBA3 SALL4 ECE1 LHX1 KMT2D TRIM28 KIAA1217 NUP133 SMARCA4 EP300 PROX1 | 2.42e-04 | 906 | 247 | 24 | GO:0043009 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 2.61e-04 | 11 | 247 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 2.66e-04 | 48 | 247 | 5 | GO:0060323 | |
| GeneOntologyBiologicalProcess | heart development | NCOA6 ABL1 TMEM94 NACA SYNPO2L MAML1 ARID1A RXRB GJA1 ACAN CACNA1G HSPG2 ANK2 SALL4 ECE1 SMARCA4 AKAP13 ASB2 TNFRSF1B EP300 PROX1 | 3.26e-04 | 757 | 247 | 21 | GO:0007507 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 3.35e-04 | 143 | 247 | 8 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA-mediated gene silencing | 3.45e-04 | 12 | 247 | 3 | GO:2000637 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.54e-04 | 51 | 247 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | lateral motor column neuron migration | 4.25e-04 | 3 | 247 | 2 | GO:0097477 | |
| GeneOntologyBiologicalProcess | spinal cord interneuron axon guidance | 4.25e-04 | 3 | 247 | 2 | GO:0097377 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing | 4.44e-04 | 13 | 247 | 3 | GO:0060148 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 4.44e-04 | 13 | 247 | 3 | GO:0060297 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing by RNA | 4.44e-04 | 13 | 247 | 3 | GO:1900370 | |
| GeneOntologyCellularComponent | chromatin | NCOA3 KDM3A ZBTB22 GATA1 E2F7 KLF3 EVX1 BCL11A SRCAP ARID1A CIC RXRB HIRA TLX1 ARID1B BBX SATB1 FOXO4 TAF4 SAP130 HOXB13 EBF4 NPAS2 EP400 CPSF6 SOX30 SALL4 RELB RFX7 CREBBP CREB3L1 LHX1 TRIM33 NKX2-4 TRIM28 TP63 H1-3 SMARCA4 ZFHX2 HSFX1 ZFHX3 TCF7L1 EP300 PROX1 | 1.75e-08 | 1480 | 250 | 44 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 2.80e-07 | 13 | 250 | 5 | GO:1990907 | |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOA3 NCOA6 GATA1 MED14 E2F7 BCL9 SSBP3 RXRB TAF4 HOXB13 ZNF541 NPAS2 SALL4 RELB CREBBP LHX1 TRIM28 TLE1 TLE3 ZFHX3 TCF7L1 EP300 | 8.84e-07 | 596 | 250 | 23 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L NCOA3 KDM3A NCOA6 MED14 E2F7 BCL11A BCL9 SRCAP ARID1A RXRB KMT2C ARID1B POM121 SCNM1 SUPT5H AFF1 TAF4 SAP130 THRAP3 MED13 ZNF541 NPAS2 EP400 CPSF6 POM121L2 RELB POM121C CREBBP KMT2D EAF1 TRIM28 TLE1 TLE3 NUP133 SMARCA4 TCF7L1 | 3.15e-06 | 1377 | 250 | 37 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | MAGEA3 MAGEA6 ABL1 MAML1 E2F7 ZMYM2 ZNF395 BCL11A UNC45A SRCAP HIRA SCNM1 SATB1 FOXO4 SAP130 MAML3 THRAP3 EP400 CPSF6 ZBTB4 MAMLD1 CREBBP EAF1 YLPM1 TENM1 ZFHX3 ATPAF2 | 1.20e-05 | 903 | 250 | 27 | GO:0016604 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | BCL9L NCOA3 MED14 E2F7 BCL9 RXRB TAF4 NPAS2 CREBBP TRIM28 TLE1 TLE3 TCF7L1 | 2.60e-05 | 272 | 250 | 13 | GO:0090575 |
| GeneOntologyCellularComponent | bBAF complex | 1.91e-04 | 10 | 250 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear speck | MAML1 E2F7 ZNF395 UNC45A SCNM1 FOXO4 SAP130 MAML3 THRAP3 EP400 CPSF6 EAF1 YLPM1 TENM1 ATPAF2 | 2.30e-04 | 431 | 250 | 15 | GO:0016607 |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.43e-04 | 12 | 250 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NCOA3 SYNRG ABL1 KIF1A DAB1 UNC45A SRCAP KCNA5 TMEM184A ATXN2 CACNA1G ANK2 PCLO APBA1 PUM2 APBA3 MAP7 ECE1 PACS1 MAP1S TENM1 AKAP13 PRKCG TNFRSF1B | 3.71e-04 | 934 | 250 | 24 | GO:0048471 |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.29e-04 | 30 | 250 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 5.58e-04 | 14 | 250 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 8.43e-04 | 16 | 250 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | acrosomal vesicle | SPATA31A7 SPATA31A6 SPATA31C1 C4BPA SPATA31A3 SPATA31A5 SPATA31A1 SPAG17 VPS13B | 8.69e-04 | 206 | 250 | 9 | GO:0001669 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.04e-03 | 96 | 250 | 6 | GO:0070603 | |
| HumanPheno | Short 5th finger | 4.51e-07 | 64 | 79 | 9 | HP:0009237 | |
| HumanPheno | Thick eyebrow | RALGAPA1 ARID1A KMT2C ARID1B SATB1 TAF4 CNOT2 CREBBP TP63 SMARCA4 MBD5 EP300 VPS13B | 5.00e-07 | 154 | 79 | 13 | HP:0000574 |
| HumanPheno | Long eyelashes | SRCAP ARID1A ARID1B CNOT2 HSPG2 CREBBP PACS1 KMT2D SMARCA4 MBD5 EP300 VPS13B | 5.04e-07 | 129 | 79 | 12 | HP:0000527 |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 5.92e-07 | 66 | 79 | 9 | HP:0006262 | |
| HumanPheno | Language impairment | RALGAPA1 KIF1A TMEM94 BCORL1 ZMYM2 DCC SRCAP ARID1A CIC ACSL4 GJA1 KMT2C ARID1B SCNM1 SATB1 ATXN2 PI4KA FBXO28 CACNA1G TAF4 HERC1 TET3 CNOT2 MED13 HSPG2 RFX7 CREBBP LHX1 PACS1 KMT2D TP63 SMARCA4 EIF3F MBD5 PUM1 RIMS2 EP300 VPS13B | 8.48e-07 | 1178 | 79 | 38 | HP:0002463 |
| HumanPheno | Sandal gap | ABL1 ARID1A ARID1B SATB1 SALL4 RFX7 CREBBP MBD5 EP300 VPS13B | 1.73e-06 | 96 | 79 | 10 | HP:0001852 |
| HumanPheno | Delayed speech and language development | RALGAPA1 KIF1A TMEM94 BCORL1 ZMYM2 DCC SRCAP ARID1A CIC ACSL4 GJA1 KMT2C ARID1B SCNM1 SATB1 PI4KA FBXO28 CACNA1G TAF4 HERC1 TET3 CNOT2 MED13 HSPG2 RFX7 CREBBP PACS1 KMT2D TP63 SMARCA4 EIF3F MBD5 PUM1 RIMS2 EP300 VPS13B | 2.46e-06 | 1123 | 79 | 36 | HP:0000750 |
| HumanPheno | Abnormality of the palpebral fissures | ABL1 BCORL1 ZMYM2 BCL11A SRCAP HIRA ACSL4 GJA1 KMT2C ARID1B SCNM1 SATB1 FBXO28 CACNA1G TAF4 HERC1 CNOT2 MED13 HSPG2 PCLO SALL4 RFX7 CREBBP PACS1 KMT2D TP63 SLC45A1 CTNND2 PUM1 EP300 VPS13B | 2.62e-06 | 880 | 79 | 31 | HP:0008050 |
| HumanPheno | Short columella | 4.11e-06 | 29 | 79 | 6 | HP:0002000 | |
| HumanPheno | Prominent eyelashes | 4.22e-06 | 17 | 79 | 5 | HP:0011231 | |
| HumanPheno | Hirsutism | SRCAP ARID1A GJA1 ARID1B CACNA1G CNOT2 HSPG2 CREBBP KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 | 4.29e-06 | 216 | 79 | 14 | HP:0001007 |
| HumanPheno | Hypertrichosis | TMEM94 GATA1 SRCAP ARID1A GJA1 ARID1B FBXO28 CACNA1G TAF4 CNOT2 MED13 HSPG2 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 | 4.42e-06 | 425 | 79 | 20 | HP:0000998 |
| HumanPheno | Abnormal eyelash morphology | GATA1 SRCAP ARID1A GJA1 ARID1B CNOT2 HSPG2 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 VPS13B | 5.06e-06 | 284 | 79 | 16 | HP:0000499 |
| HumanPheno | Autistic behavior | BCORL1 ZMYM2 BCL11A SRCAP ARID1A CIC HIRA ACSL4 KMT2C ARID1B SATB1 FBXO28 TAF4 TET3 MED13 HSPG2 RFX7 CREBBP LHX1 PACS1 KMT2D SMARCA4 MBD5 RIMS2 EP300 VPS13B | 5.25e-06 | 678 | 79 | 26 | HP:0000729 |
| HumanPheno | Partial absence of cerebellar vermis | 6.49e-06 | 66 | 79 | 8 | HP:0002951 | |
| HumanPheno | Delayed gross motor development | TMEM94 BCORL1 BCL11A SRCAP GJA1 KMT2C ARID1B SATB1 PI4KA CACNA1G TAF4 ROBO3 TET3 MED13 MPZ CREBBP EIF3F MBD5 PUM1 EP300 VPS13B | 7.89e-06 | 481 | 79 | 21 | HP:0002194 |
| HumanPheno | Abnormality of the hairline | RALGAPA1 GATA1 SRCAP ARID1A ARID1B SCNM1 SATB1 HSPG2 SALL4 CREBBP PACS1 KMT2D SMARCA4 MBD5 EP300 VPS13B | 7.91e-06 | 294 | 79 | 16 | HP:0009553 |
| HumanPheno | Abnormal nasal septum morphology | 9.03e-06 | 115 | 79 | 10 | HP:0000419 | |
| HumanPheno | Diagnostic behavioral phenotype | BCORL1 ZMYM2 BCL11A SRCAP ARID1A CIC HIRA ACSL4 KMT2C ARID1B SATB1 FBXO28 TAF4 TET3 MED13 HSPG2 RFX7 CREBBP LHX1 PACS1 KMT2D RBM12 SMARCA4 MBD5 RIMS2 EP300 VPS13B | 9.95e-06 | 747 | 79 | 27 | HP:0025783 |
| HumanPheno | Abnormal toe morphology | ABL1 KIF1A TMEM94 ZMYM2 ARID1A CIC HIRA GJA1 ARID1B SCNM1 SATB1 ACAN FBXO28 TAF4 HERC1 CNOT2 MPZ HSPG2 SALL4 RFX7 ECE1 CREBBP KMT2D TP63 NUP133 SMARCA4 MBD5 PUM1 EP300 VPS13B | 1.13e-05 | 893 | 79 | 30 | HP:0001780 |
| HumanPheno | Abnormal columella morphology | 1.55e-05 | 97 | 79 | 9 | HP:0009929 | |
| HumanPheno | Abnormal eyebrow morphology | RALGAPA1 ABL1 TMEM94 ARID1A GJA1 KMT2C ARID1B SATB1 PI4KA FBXO28 TAF4 HERC1 CNOT2 MED13 HSPG2 CREBBP PACS1 KMT2D TP63 SMARCA4 SLC45A1 MBD5 PUM1 EP300 VPS13B | 1.56e-05 | 674 | 79 | 25 | HP:0000534 |
| HumanPheno | Abnormal hair pattern | RALGAPA1 TMEM94 GATA1 SRCAP ARID1A GJA1 ARID1B SCNM1 SATB1 FBXO28 CACNA1G TAF4 CNOT2 MED13 HSPG2 SALL4 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 VPS13B | 1.64e-05 | 676 | 79 | 25 | HP:0010720 |
| HumanPheno | Wide nasal bridge | TMEM94 GATA1 ZMYM2 SRCAP HIRA GJA1 ARID1B SCNM1 TAF4 MED13 HSPG2 COL27A1 SALL4 RFX7 CREBBP KMT2D TP63 SMARCA4 CTNND2 PUM1 EP300 | 1.85e-05 | 508 | 79 | 21 | HP:0000431 |
| HumanPheno | Ventricular septal defect | ABL1 TMEM94 GATA1 ZMYM2 ARID1A HIRA GJA1 ARID1B SATB1 PI4KA TET3 SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 SMARCA4 EP300 VPS13B | 1.96e-05 | 510 | 79 | 21 | HP:0001629 |
| HumanPheno | Abnormality of the scalp hair | RALGAPA1 GATA1 SRCAP ARID1A GJA1 ARID1B SCNM1 SATB1 PI4KA HSPG2 SALL4 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 EP300 VPS13B | 2.23e-05 | 433 | 79 | 19 | HP:0100037 |
| HumanPheno | Joint hypermobility | ABL1 ZMYM2 BCL11A SRCAP ARID1A HIRA ARID1B SATB1 ACAN TAF4 HERC1 TET3 MAMLD1 RFX7 CREBBP CREB3L1 KMT2D SMARCA4 CTNND2 PUM1 EP300 VPS13B | 2.27e-05 | 557 | 79 | 22 | HP:0001382 |
| HumanPheno | Abnormal nasal bridge morphology | RALGAPA1 TMEM94 GATA1 ZMYM2 SRCAP ARID1A HIRA ACSL4 GJA1 ARID1B SCNM1 ACAN FBXO28 TAF4 HERC1 MED13 HSPG2 COL27A1 PCLO SALL4 RFX7 ECE1 CREBBP KMT2D TP63 SMARCA4 SLC45A1 CTNND2 PUM1 EP300 VPS13B ATPAF2 | 2.54e-05 | 1029 | 79 | 32 | HP:0000422 |
| HumanPheno | Abnormal ventricular septum morphology | ABL1 TMEM94 GATA1 ZMYM2 ARID1A HIRA GJA1 ARID1B SATB1 PI4KA TET3 SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 SMARCA4 EP300 VPS13B | 2.72e-05 | 521 | 79 | 21 | HP:0010438 |
| HumanPheno | Abnormality of the lower urinary tract | RALGAPA1 ABL1 KIF1A TMEM94 GATA1 ZMYM2 UNC45A SRCAP ARID1A HIRA GJA1 KMT2C ARID1B SATB1 ATXN2 PI4KA CACNA1G IL17RA MPZ HSPG2 MAMLD1 SALL4 RELB CREBBP KMT2D TRIM28 TP63 SMARCA4 PUM1 EP300 | 2.99e-05 | 937 | 79 | 30 | HP:0010936 |
| HumanPheno | Congenital abnormal hair pattern | RALGAPA1 GATA1 SRCAP ARID1A ARID1B SCNM1 SATB1 HSPG2 SALL4 CREBBP PACS1 KMT2D SMARCA4 MBD5 EP300 VPS13B | 3.02e-05 | 327 | 79 | 16 | HP:0011361 |
| HumanPheno | Cerebellar vermis atrophy | 3.29e-05 | 60 | 79 | 7 | HP:0006855 | |
| HumanPheno | Abnormal scalp morphology | RALGAPA1 GATA1 SRCAP ARID1A GJA1 ARID1B SCNM1 SATB1 PI4KA HSPG2 SALL4 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 EP300 VPS13B | 3.83e-05 | 450 | 79 | 19 | HP:0001965 |
| HumanPheno | Agenesis of cerebellar vermis | 3.94e-05 | 84 | 79 | 8 | HP:0002335 | |
| HumanPheno | Abnormal size of the palpebral fissures | ZMYM2 SRCAP GJA1 FBXO28 CACNA1G TAF4 MED13 HSPG2 PCLO SALL4 RFX7 CREBBP KMT2D TP63 EP300 | 4.02e-05 | 298 | 79 | 15 | HP:0200007 |
| HumanPheno | Hypospadias | ABL1 TMEM94 GATA1 ZMYM2 SRCAP ARID1A HIRA ARID1B HSPG2 MAMLD1 CREBBP KMT2D TRIM28 TP63 SMARCA4 PUM1 EP300 | 4.69e-05 | 377 | 79 | 17 | HP:0000047 |
| HumanPheno | Long fingers | ABL1 KIF1A TMEM94 BCORL1 ZMYM2 CIC HIRA ACSL4 GJA1 KMT2C HERC1 RFX7 ECE1 PUM1 VPS13B | 5.47e-05 | 306 | 79 | 15 | HP:0100807 |
| HumanPheno | Abnormal 5th finger morphology | ABL1 ZMYM2 SRCAP ARID1A GJA1 ARID1B SCNM1 TAF4 CNOT2 HSPG2 COL27A1 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 VPS13B | 6.44e-05 | 509 | 79 | 20 | HP:0004207 |
| HumanPheno | Carious teeth | ABL1 ZMYM2 SRCAP HIRA GJA1 SCNM1 SATB1 CREBBP KMT2D TP63 EP300 | 6.45e-05 | 174 | 79 | 11 | HP:0000670 |
| HumanPheno | Prominent interphalangeal joints | 6.94e-05 | 6 | 79 | 3 | HP:0006237 | |
| HumanPheno | Abnormal hand morphology | ABL1 KIF1A TMEM94 GATA1 ZMYM2 SRCAP ARID1A HIRA GJA1 ARID1B SCNM1 SATB1 ACAN PI4KA FBXO28 TAF4 HERC1 CNOT2 MPZ HSPG2 COL27A1 SALL4 CREBBP PACS1 KMT2D TP63 SMARCA4 CTNND2 MBD5 PUM1 EP300 VPS13B | 7.22e-05 | 1082 | 79 | 32 | HP:0005922 |
| HumanPheno | Low anterior hairline | RALGAPA1 GATA1 ARID1A ARID1B HSPG2 CREBBP PACS1 SMARCA4 EP300 VPS13B | 7.71e-05 | 147 | 79 | 10 | HP:0000294 |
| HumanPheno | Thin vermilion border | ABL1 TMEM94 BCL11A SRCAP ARID1A ACSL4 GJA1 ARID1B CNOT2 MED13 RFX7 CREBBP PACS1 KMT2D SMARCA4 SLC45A1 MBD5 EP300 | 7.90e-05 | 433 | 79 | 18 | HP:0000233 |
| HumanPheno | Displacement of the urethral meatus | ABL1 TMEM94 GATA1 ZMYM2 SRCAP ARID1A HIRA ARID1B HSPG2 MAMLD1 CREBBP KMT2D TRIM28 TP63 SMARCA4 PUM1 EP300 | 9.01e-05 | 397 | 79 | 17 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | ABL1 TMEM94 GATA1 ZMYM2 SRCAP ARID1A HIRA ARID1B HSPG2 MAMLD1 CREBBP KMT2D TRIM28 TP63 SMARCA4 PUM1 EP300 | 9.59e-05 | 399 | 79 | 17 | HP:0032076 |
| HumanPheno | Narrow palpebral fissure | 9.88e-05 | 71 | 79 | 7 | HP:0045025 | |
| HumanPheno | Aplasia/Hypoplasia involving the nose | ABL1 TMEM94 ZMYM2 SRCAP ARID1A GJA1 ARID1B SCNM1 CACNA1G TAF4 RFX7 ECE1 CREBBP KMT2D TP63 SMARCA4 MBD5 | 1.02e-04 | 401 | 79 | 17 | HP:0009924 |
| HumanPheno | Short finger | GATA1 ZMYM2 SRCAP ARID1A GJA1 ARID1B ACAN CNOT2 SALL4 CREBBP KMT2D SMARCA4 MBD5 PUM1 EP300 | 1.09e-04 | 325 | 79 | 15 | HP:0009381 |
| HumanPheno | Oral aversion | 1.09e-04 | 17 | 79 | 4 | HP:0012523 | |
| HumanPheno | Abnormal thought pattern | BCORL1 ZMYM2 BCL11A SRCAP CIC ARID1B SATB1 FBXO28 TAF4 HSPG2 RFX7 CREBBP TP63 SLC45A1 MBD5 PUM1 EP300 | 1.12e-04 | 404 | 79 | 17 | HP:5200269 |
| HumanPheno | Cerebellar hypoplasia | KIF1A DAB1 BCL11A ARID1A KMT2C ARID1B ATXN2 PI4KA CACNA1G TAF4 HERC1 ROBO3 PCLO RFX7 PACS1 SMARCA4 PRKCG MBD5 PUM1 VPS13B | 1.14e-04 | 530 | 79 | 20 | HP:0001321 |
| HumanPheno | Clinodactyly | ABL1 ZMYM2 SRCAP ARID1A GJA1 ARID1B CACNA1G TAF4 CNOT2 HSPG2 COL27A1 RFX7 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 VPS13B | 1.15e-04 | 574 | 79 | 21 | HP:0030084 |
| HumanPheno | Aplasia/Hypoplasia of fingers | GATA1 ZMYM2 SRCAP ARID1A GJA1 ARID1B ACAN CNOT2 SALL4 CREBBP KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 | 1.18e-04 | 366 | 79 | 16 | HP:0006265 |
| HumanPheno | Restricted or repetitive behaviors or interests | BCORL1 ZMYM2 BCL11A SRCAP CIC ARID1B SATB1 FBXO28 TAF4 HSPG2 RFX7 CREBBP SLC45A1 MBD5 PUM1 EP300 | 1.26e-04 | 368 | 79 | 16 | HP:0031432 |
| HumanPheno | Abnormal finger morphology | ABL1 KIF1A TMEM94 BCORL1 GATA1 ZMYM2 SRCAP ARID1A CIC HIRA ACSL4 GJA1 KMT2C ARID1B SCNM1 ACAN PI4KA FBXO28 IL17RA TAF4 HERC1 CNOT2 HSPG2 COL27A1 SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 NUP133 SMARCA4 MBD5 PUM1 EP300 VPS13B | 1.32e-04 | 1385 | 79 | 37 | HP:0001167 |
| HumanPheno | Intestinal malrotation | 1.34e-04 | 157 | 79 | 10 | HP:0002566 | |
| HumanPheno | Aplasia/Hypoplasia of the cerebellum | KIF1A DAB1 BCL11A ARID1A GJA1 KMT2C ARID1B ATXN2 PI4KA CACNA1G TAF4 HERC1 ROBO3 PCLO RFX7 PACS1 SMARCA4 PRKCG MBD5 PUM1 VPS13B | 1.37e-04 | 581 | 79 | 21 | HP:0007360 |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | GATA1 ZMYM2 SRCAP ARID1A GJA1 ARID1B SATB1 ACAN FBXO28 CNOT2 SALL4 CREBBP KMT2D TP63 SMARCA4 CTNND2 MBD5 PUM1 EP300 VPS13B | 1.40e-04 | 538 | 79 | 20 | HP:0005927 |
| HumanPheno | Abnormal external nose morphology | RALGAPA1 TMEM94 ZMYM2 BCL11A SRCAP ARID1A HIRA ACSL4 GJA1 ARID1B SCNM1 FBXO28 TAF4 CNOT2 HSPG2 COL27A1 SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 VPS13B | 1.48e-04 | 916 | 79 | 28 | HP:0010938 |
| HumanPheno | Downslanted palpebral fissures | BCORL1 ZMYM2 BCL11A HIRA ACSL4 GJA1 ARID1B SCNM1 SATB1 FBXO28 TAF4 HERC1 CREBBP PACS1 KMT2D SLC45A1 CTNND2 EP300 VPS13B | 1.49e-04 | 497 | 79 | 19 | HP:0000494 |
| HumanPheno | Perseverative thought | BCORL1 ZMYM2 BCL11A SRCAP CIC ARID1B SATB1 FBXO28 TAF4 HSPG2 RFX7 CREBBP SLC45A1 MBD5 PUM1 EP300 | 1.68e-04 | 377 | 79 | 16 | HP:0030223 |
| HumanPheno | Abnormal eyelid morphology | ABL1 BCORL1 GATA1 ZMYM2 BCL11A SRCAP ARID1A HIRA ACSL4 GJA1 KMT2C ARID1B PNPLA1 SCNM1 SATB1 FBXO28 CACNA1G TAF4 HERC1 CNOT2 MED13 HSPG2 PCLO SALL4 RFX7 CREBBP PACS1 KMT2D TP63 SMARCA4 SLC45A1 TNFRSF1B CTNND2 MBD5 PUM1 EP300 VPS13B | 1.91e-04 | 1408 | 79 | 37 | HP:0000492 |
| HumanPheno | Patent ductus arteriosus | TMEM94 ZMYM2 ARID1A HIRA ACSL4 GJA1 ARID1B HSPG2 SALL4 ECE1 CREBBP PACS1 KMT2D TP63 SMARCA4 EP300 | 1.95e-04 | 382 | 79 | 16 | HP:0001643 |
| HumanPheno | Abnormal pinna morphology | RALGAPA1 TMEM94 GATA1 ZMYM2 BCL11A SRCAP ARID1A HIRA GJA1 KMT2C ARID1B SCNM1 SATB1 ACAN CACNA1G TAF4 HERC1 TET3 CNOT2 HSPG2 PCLO SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 NUP133 EIF3F CTNND2 MBD5 PUM1 EP300 VPS13B | 1.96e-04 | 1299 | 79 | 35 | HP:0000377 |
| HumanPheno | Expressive language delay | 2.01e-04 | 56 | 79 | 6 | HP:0002474 | |
| HumanPheno | Language delay | 2.01e-04 | 56 | 79 | 6 | HP:0002336 | |
| HumanPheno | Low hanging columella | 2.01e-04 | 56 | 79 | 6 | HP:0009765 | |
| HumanPheno | Nasolacrimal duct obstruction | 2.04e-04 | 36 | 79 | 5 | HP:0000579 | |
| HumanPheno | Disordered formal thought process | BCORL1 ZMYM2 BCL11A SRCAP CIC ARID1B SATB1 FBXO28 TAF4 HSPG2 RFX7 CREBBP SLC45A1 MBD5 PUM1 EP300 | 2.20e-04 | 386 | 79 | 16 | HP:0025769 |
| HumanPheno | Steroetypic upper-extremity movements | 2.22e-04 | 57 | 79 | 6 | HP:5200018 | |
| HumanPheno | Abnormal earlobe morphology | 2.36e-04 | 137 | 79 | 9 | HP:0000363 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.38e-04 | 2 | 79 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 2.38e-04 | 2 | 79 | 2 | HP:0008107 | |
| HumanPheno | High axial triradius | 2.38e-04 | 2 | 79 | 2 | HP:0001042 | |
| HumanPheno | Brachydactyly (hand) | GATA1 ZMYM2 SRCAP ARID1A GJA1 ARID1B ACAN CNOT2 SALL4 CREBBP PACS1 KMT2D TP63 SMARCA4 MBD5 PUM1 EP300 | 2.40e-04 | 430 | 79 | 17 | HP:0100667 |
| HumanPheno | Abnormal location of ears | RALGAPA1 TMEM94 GATA1 ZMYM2 BCL11A SRCAP HIRA GJA1 ARID1B SCNM1 SATB1 ACAN CACNA1G TAF4 HERC1 CNOT2 HSPG2 PCLO RFX7 ECE1 CREBBP PACS1 KMT2D EIF3F CTNND2 MBD5 PUM1 EP300 | 2.57e-04 | 945 | 79 | 28 | HP:0000357 |
| HumanPheno | Localized hirsutism | 2.62e-04 | 21 | 79 | 4 | HP:0009889 | |
| HumanPheno | Abnormal midface morphology | ABL1 BCL11A SRCAP HIRA ACSL4 GJA1 KMT2C ARID1B SATB1 ACAN HERC1 HSPG2 COL27A1 PCLO SALL4 RFX7 CREBBP KMT2D TP63 CTNND2 MBD5 EP300 VPS13B | 2.79e-04 | 704 | 79 | 23 | HP:0000309 |
| HumanPheno | Pilomatrixoma | 2.82e-04 | 9 | 79 | 3 | HP:0030434 | |
| HumanPheno | Laryngomalacia | 2.86e-04 | 84 | 79 | 7 | HP:0001601 | |
| HumanPheno | Tapered finger | 2.93e-04 | 141 | 79 | 9 | HP:0001182 | |
| HumanPheno | Abnormal lower lip morphology | BCL11A SRCAP ARID1A KMT2C ARID1B SCNM1 TAF4 HSPG2 SALL4 KMT2D SMARCA4 MBD5 | 3.01e-04 | 242 | 79 | 12 | HP:0000178 |
| HumanPheno | Supernumerary tooth | 3.08e-04 | 85 | 79 | 7 | HP:0011069 | |
| HumanPheno | Abnormal curvature of the vertebral column | ABL1 KIF1A TMEM94 ZMYM2 DCC SRCAP ARID1A CIC HIRA KMT2C ARID1B SATB1 ACAN PI4KA FBXO28 CACNA1G TAF4 HERC1 ROBO3 CNOT2 MPZ HSPG2 COL27A1 SALL4 CREBBP PACS1 KMT2D SMARCA4 CTNND2 MBD5 PUM1 EP300 VPS13B | 3.14e-04 | 1219 | 79 | 33 | HP:0010674 |
| HumanPheno | Motor stereotypy | BCORL1 ZMYM2 BCL11A CIC SATB1 FBXO28 TAF4 HSPG2 RFX7 CREBBP MBD5 PUM1 EP300 | 3.15e-04 | 280 | 79 | 13 | HP:0000733 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | GATA1 ZMYM2 SRCAP ARID1A GJA1 ARID1B SATB1 ACAN FBXO28 CNOT2 SALL4 CREBBP KMT2D TP63 SMARCA4 CTNND2 MBD5 PUM1 EP300 VPS13B | 3.23e-04 | 572 | 79 | 20 | HP:0006496 |
| HumanPheno | Abnormality of the pharynx | IRF2BP2 ARID1A HIRA GJA1 ARID1B IL17RA HSPG2 SALL4 RELB RFX7 CREBBP TP63 SMARCA4 EP300 | 3.34e-04 | 320 | 79 | 14 | HP:0000600 |
| HumanPheno | Cerebellar malformation | KIF1A TMEM94 DAB1 BCL11A ARID1A ARID1B PI4KA CACNA1G TAF4 RFX7 CREBBP PACS1 KMT2D SMARCA4 PRKCG MBD5 PUM1 EP300 | 3.53e-04 | 487 | 79 | 18 | HP:0002438 |
| HumanPheno | Abnormality of the outer ear | RALGAPA1 TMEM94 GATA1 ZMYM2 BCL11A SRCAP ARID1A HIRA GJA1 KMT2C ARID1B SCNM1 SATB1 ACAN CACNA1G TAF4 HERC1 TET3 CNOT2 HSPG2 PCLO SALL4 RFX7 ECE1 CREBBP PACS1 KMT2D TP63 NUP133 EIF3F CTNND2 MBD5 PUM1 EP300 VPS13B | 3.59e-04 | 1337 | 79 | 35 | HP:0000356 |
| HumanPheno | Long nose | 3.82e-04 | 41 | 79 | 5 | HP:0003189 | |
| HumanPheno | Abnormal nasopharynx morphology | IRF2BP2 ARID1A GJA1 ARID1B IL17RA SALL4 RELB RFX7 CREBBP TP63 SMARCA4 EP300 | 3.92e-04 | 249 | 79 | 12 | HP:0001739 |
| HumanPheno | Pes planus | ABL1 DCC CIC TAF4 HERC1 TET3 MPZ HSPG2 COL27A1 SALL4 CREBBP PACS1 EIF3F EP300 VPS13B | 3.93e-04 | 365 | 79 | 15 | HP:0001763 |
| HumanPheno | Abnormality of the frontal hairline | RALGAPA1 GATA1 ARID1A ARID1B SATB1 HSPG2 CREBBP PACS1 SMARCA4 EP300 VPS13B | 4.21e-04 | 215 | 79 | 11 | HP:0000599 |
| HumanPheno | Abnormality of dental structure | ABL1 GATA1 ZMYM2 SRCAP HIRA GJA1 SCNM1 SATB1 FBXO28 IL17RA CREBBP KMT2D TP63 NUP133 EP300 | 4.29e-04 | 368 | 79 | 15 | HP:0011061 |
| HumanPheno | Abnormally folded helix | 4.38e-04 | 90 | 79 | 7 | HP:0008544 | |
| HumanPheno | Abnormality of the dentition | ABL1 GATA1 ZMYM2 DCC SRCAP ARID1A HIRA ACSL4 GJA1 KMT2C ARID1B SCNM1 SATB1 FBXO28 IL17RA TAF4 CNOT2 HSPG2 CREBBP CREB3L1 PACS1 KMT2D TP63 NUP133 SMARCA4 MBD5 PUM1 EP300 VPS13B | 4.65e-04 | 1030 | 79 | 29 | HP:0000164 |
| HumanPheno | Hypoplastic facial bones | SRCAP HIRA ACSL4 GJA1 ARID1B ACAN HERC1 HSPG2 RFX7 CREBBP TP63 MBD5 EP300 VPS13B | 4.73e-04 | 331 | 79 | 14 | HP:0002692 |
| HumanPheno | Hernia | ABL1 TMEM94 SRCAP ARID1A HIRA GJA1 KMT2C ARID1B PI4KA TAF4 HSPG2 MAMLD1 RFX7 CREBBP PACS1 KMT2D TP63 NUP133 SMARCA4 CTNND2 | 4.77e-04 | 589 | 79 | 20 | HP:0100790 |
| HumanPheno | Juvenile aseptic necrosis | 4.79e-04 | 43 | 79 | 5 | HP:0100323 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | ABL1 ZMYM2 SRCAP GJA1 ARID1B TAF4 CNOT2 HSPG2 COL27A1 SALL4 CREBBP PACS1 KMT2D TP63 MBD5 EP300 VPS13B | 4.82e-04 | 456 | 79 | 17 | HP:0009485 |
| MousePheno | abnormal fluid regulation | NCOA6 RIPK1 NACA ZMYM2 ARID1A HIRA GJA1 ARID1B PNPLA1 ACAN IL17RA BAG6 CEP97 PRRC2B HSPG2 COL27A1 SALL4 RELB ECE1 ADGRG2 TP63 NUP133 AKAP13 HMGXB3 SPAG17 TCF7L1 EP300 PROX1 | 1.51e-05 | 826 | 198 | 28 | MP:0001784 |
| Domain | DUF4599 | 3.40e-09 | 12 | 237 | 6 | PF15371 | |
| Domain | DUF4599 | 3.40e-09 | 12 | 237 | 6 | IPR027970 | |
| Domain | HMG_box_dom | 1.26e-07 | 65 | 237 | 9 | IPR009071 | |
| Domain | HMG_box | 3.24e-07 | 53 | 237 | 8 | PF00505 | |
| Domain | HMG | 3.76e-07 | 54 | 237 | 8 | SM00398 | |
| Domain | - | 5.86e-06 | 55 | 237 | 7 | 1.10.30.10 | |
| Domain | HSA | 8.00e-06 | 4 | 237 | 3 | SM00573 | |
| Domain | LRRC37AB_C | 8.00e-06 | 4 | 237 | 3 | IPR029423 | |
| Domain | HSA | 8.00e-06 | 4 | 237 | 3 | PS51204 | |
| Domain | LRRC37AB_C | 8.00e-06 | 4 | 237 | 3 | PF14914 | |
| Domain | LRRC37_N | 8.00e-06 | 4 | 237 | 3 | IPR032754 | |
| Domain | LRRC37 | 8.00e-06 | 4 | 237 | 3 | PF15779 | |
| Domain | HSA_dom | 8.00e-06 | 4 | 237 | 3 | IPR014012 | |
| Domain | HSA | 8.00e-06 | 4 | 237 | 3 | PF07529 | |
| Domain | LRRC37A/B-like | 8.00e-06 | 4 | 237 | 3 | IPR015753 | |
| Domain | Nuc_rcpt_coact | 3.92e-05 | 6 | 237 | 3 | IPR009110 | |
| Domain | HMG_BOX_2 | 6.08e-05 | 54 | 237 | 6 | PS50118 | |
| Domain | BROMODOMAIN_1 | 9.87e-05 | 37 | 237 | 5 | PS00633 | |
| Domain | Znf_FYVE_PHD | 1.11e-04 | 147 | 237 | 9 | IPR011011 | |
| Domain | PDZ | 1.36e-04 | 151 | 237 | 9 | PS50106 | |
| Domain | PDZ | 1.43e-04 | 152 | 237 | 9 | IPR001478 | |
| Domain | PTB | 1.44e-04 | 40 | 237 | 5 | SM00462 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.60e-04 | 2 | 237 | 2 | IPR014744 | |
| Domain | BCL9 | 1.60e-04 | 2 | 237 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 1.60e-04 | 2 | 237 | 2 | SM00551 | |
| Domain | - | 1.60e-04 | 2 | 237 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.60e-04 | 2 | 237 | 2 | IPR010303 | |
| Domain | - | 1.60e-04 | 2 | 237 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.60e-04 | 2 | 237 | 2 | PF09030 | |
| Domain | zf-TAZ | 1.60e-04 | 2 | 237 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.60e-04 | 2 | 237 | 2 | PS50134 | |
| Domain | Pumilio_RNA-bd | 1.60e-04 | 2 | 237 | 2 | IPR033712 | |
| Domain | BAF250/Osa | 1.60e-04 | 2 | 237 | 2 | IPR021906 | |
| Domain | KAT11 | 1.60e-04 | 2 | 237 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.60e-04 | 2 | 237 | 2 | IPR000197 | |
| Domain | KIX | 1.60e-04 | 2 | 237 | 2 | PF02172 | |
| Domain | Bcl-9 | 1.60e-04 | 2 | 237 | 2 | IPR015668 | |
| Domain | BCL9_beta-catenin-bd_dom | 1.60e-04 | 2 | 237 | 2 | IPR024670 | |
| Domain | BAF250_C | 1.60e-04 | 2 | 237 | 2 | IPR033388 | |
| Domain | HAT_KAT11 | 1.60e-04 | 2 | 237 | 2 | PF08214 | |
| Domain | KIX | 1.60e-04 | 2 | 237 | 2 | PS50952 | |
| Domain | MAGEA3/MAGEA6 | 1.60e-04 | 2 | 237 | 2 | IPR030097 | |
| Domain | CBP_P300_HAT | 1.60e-04 | 2 | 237 | 2 | IPR031162 | |
| Domain | DUF902 | 1.60e-04 | 2 | 237 | 2 | PF06001 | |
| Domain | - | 1.60e-04 | 2 | 237 | 2 | 1.10.246.20 | |
| Domain | BAF250_C | 1.60e-04 | 2 | 237 | 2 | PF12031 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.60e-04 | 2 | 237 | 2 | IPR013178 | |
| Domain | KIX_dom | 1.60e-04 | 2 | 237 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 1.60e-04 | 2 | 237 | 2 | PS51727 | |
| Domain | PTB/PI_dom | 1.63e-04 | 41 | 237 | 5 | IPR006020 | |
| Domain | BROMODOMAIN_2 | 1.63e-04 | 41 | 237 | 5 | PS50014 | |
| Domain | Bromodomain | 1.83e-04 | 42 | 237 | 5 | IPR001487 | |
| Domain | BROMO | 1.83e-04 | 42 | 237 | 5 | SM00297 | |
| Domain | - | 1.83e-04 | 42 | 237 | 5 | 1.20.920.10 | |
| Domain | AT_hook | 3.53e-04 | 27 | 237 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 3.53e-04 | 27 | 237 | 4 | IPR017956 | |
| Domain | PID | 4.07e-04 | 28 | 237 | 4 | PF00640 | |
| Domain | PUF | 4.77e-04 | 3 | 237 | 2 | PF00806 | |
| Domain | MamL-1 | 4.77e-04 | 3 | 237 | 2 | SM01275 | |
| Domain | PUM_HD | 4.77e-04 | 3 | 237 | 2 | PS50303 | |
| Domain | Neuroggenic_mastermind-like_N | 4.77e-04 | 3 | 237 | 2 | IPR019082 | |
| Domain | PUM-HD | 4.77e-04 | 3 | 237 | 2 | IPR033133 | |
| Domain | SSDP_DNA-bd | 4.77e-04 | 3 | 237 | 2 | IPR008116 | |
| Domain | MamL-1 | 4.77e-04 | 3 | 237 | 2 | PF09596 | |
| Domain | PDZ | 6.13e-04 | 148 | 237 | 8 | SM00228 | |
| Domain | SEA | 6.62e-04 | 14 | 237 | 3 | SM00200 | |
| Domain | - | 6.70e-04 | 150 | 237 | 8 | 2.30.42.10 | |
| Domain | PID | 6.88e-04 | 32 | 237 | 4 | PS01179 | |
| Domain | Bbox_C | 8.20e-04 | 15 | 237 | 3 | IPR003649 | |
| Domain | BBC | 8.20e-04 | 15 | 237 | 3 | SM00502 | |
| Domain | HMGI_Y | 9.46e-04 | 4 | 237 | 2 | PS00354 | |
| Domain | PUM | 9.46e-04 | 4 | 237 | 2 | PS50302 | |
| Domain | MAP7 | 9.46e-04 | 4 | 237 | 2 | PF05672 | |
| Domain | Pumilio_RNA-bd_rpt | 9.46e-04 | 4 | 237 | 2 | IPR001313 | |
| Domain | MAP7_fam | 9.46e-04 | 4 | 237 | 2 | IPR008604 | |
| Domain | Pumilio | 9.46e-04 | 4 | 237 | 2 | SM00025 | |
| Domain | AT_hook | 1.00e-03 | 16 | 237 | 3 | PF02178 | |
| Domain | C2_dom | 1.20e-03 | 164 | 237 | 8 | IPR000008 | |
| Domain | Bromodomain | 1.33e-03 | 38 | 237 | 4 | PF00439 | |
| Domain | - | KIF1A DAB1 ARHGEF17 ARHGAP20 AGAP2 GULP1 PHLDB3 APBA1 APBA3 GAB3 AKAP13 TNS1 PHLDB2 | 1.53e-03 | 391 | 237 | 13 | 2.30.29.30 |
| Domain | FYrich_C | 1.56e-03 | 5 | 237 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.56e-03 | 5 | 237 | 2 | IPR003888 | |
| Domain | FYRC | 1.56e-03 | 5 | 237 | 2 | SM00542 | |
| Domain | FYRN | 1.56e-03 | 5 | 237 | 2 | SM00541 | |
| Domain | Groucho_enhance | 1.56e-03 | 5 | 237 | 2 | IPR009146 | |
| Domain | TAFH | 1.56e-03 | 5 | 237 | 2 | SM00549 | |
| Domain | TLE_N | 1.56e-03 | 5 | 237 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.56e-03 | 5 | 237 | 2 | IPR005617 | |
| Domain | TAFH_NHR1 | 1.56e-03 | 5 | 237 | 2 | IPR003894 | |
| Domain | TAFH | 1.56e-03 | 5 | 237 | 2 | PS51119 | |
| Domain | FYRN | 1.56e-03 | 5 | 237 | 2 | PF05964 | |
| Domain | FYRC | 1.56e-03 | 5 | 237 | 2 | PF05965 | |
| Domain | FYRC | 1.56e-03 | 5 | 237 | 2 | PS51543 | |
| Domain | FYRN | 1.56e-03 | 5 | 237 | 2 | PS51542 | |
| Domain | TAFH | 1.56e-03 | 5 | 237 | 2 | PF07531 | |
| Domain | PDZ | 2.17e-03 | 141 | 237 | 7 | PF00595 | |
| Domain | SEA | 2.60e-03 | 22 | 237 | 3 | PF01390 | |
| Domain | - | 2.86e-03 | 148 | 237 | 7 | 2.60.40.150 | |
| Domain | SEA | 2.96e-03 | 23 | 237 | 3 | PS50024 | |
| Domain | SEA_dom | 2.96e-03 | 23 | 237 | 3 | IPR000082 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.92e-10 | 26 | 170 | 8 | MM14793 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.41e-07 | 14 | 170 | 5 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 9.43e-07 | 16 | 170 | 5 | M27121 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.06e-06 | 29 | 170 | 6 | M48076 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.07e-06 | 65 | 170 | 8 | M39682 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.47e-06 | 91 | 170 | 9 | M27101 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.59e-06 | 48 | 170 | 7 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.81e-06 | 18 | 170 | 5 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.91e-06 | 74 | 170 | 8 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.22e-06 | 20 | 170 | 5 | M27881 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | KDM3A ZMYM2 HIRA SATB1 EP400 SALL4 RELB CREBBP TRIM33 KMT2D TRIM28 SMARCA4 PRKCG TCF7L1 EP300 | 3.65e-06 | 301 | 170 | 15 | MM15983 |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.05e-06 | 10 | 170 | 4 | MM15535 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.36e-06 | 22 | 170 | 5 | MM1370 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.37e-06 | 12 | 170 | 4 | M27159 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.03e-05 | 42 | 170 | 6 | M27272 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.05e-05 | 25 | 170 | 5 | M27880 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.27e-05 | 118 | 170 | 9 | M27316 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.51e-05 | 15 | 170 | 4 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.51e-05 | 15 | 170 | 4 | M10183 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.68e-05 | 30 | 170 | 5 | M207 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ABL1 ZNF189 GATA1 MAML1 E2F7 ARID1A RXRB POM121 NUAK1 SUPT5H FOXO4 RPRD2 TAF4 PRKAG2 MAML3 CNOT2 CPSF6 MAMLD1 POM121C KMT2D EAF1 TRIM28 TP63 NUP133 SMARCA4 ZFHX3 TCF7L1 EP300 | 3.48e-05 | 1022 | 170 | 28 | MM15436 |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.97e-05 | 80 | 170 | 7 | M223 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 6.80e-05 | 84 | 170 | 7 | M1008 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA3 NCOA6 ABL1 DAB1 MAML1 MED14 DCC ARID1A HIRA KMT2C ARID1B FOXO4 CACNA1G ROBO3 TET3 MAML3 THRAP3 CNOT2 MED13 AGAP2 MPZ ANK2 MAMLD1 TPRX2 SALL4 CREBBP LHX1 TRIM33 KMT2D TP63 CSPG4 SMARCA4 TCF7L1 EP300 | 8.47e-05 | 1432 | 170 | 34 | M509 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.93e-05 | 39 | 170 | 5 | MM14604 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ABL1 ZNF189 GATA1 MAML1 E2F7 ARID1A RXRB NUAK1 SUPT5H FOXO4 TAF4 PRKAG2 MAML3 CNOT2 MAMLD1 KMT2D TRIM28 TP63 SMARCA4 ZFHX3 TCF7L1 EP300 | 1.40e-04 | 768 | 170 | 22 | MM14851 |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.43e-04 | 42 | 170 | 5 | M17541 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.59e-04 | 96 | 170 | 7 | M27784 | |
| Pathway | REACTOME_GASTRULATION | 1.68e-04 | 129 | 170 | 8 | M46433 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.80e-04 | 24 | 170 | 4 | M13404 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.94e-04 | 10 | 170 | 3 | MM15156 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.94e-04 | 10 | 170 | 3 | M27945 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ABL1 ZNF189 GATA1 MAML1 MED14 E2F7 ARID1A RXRB KMT2C ARID1B NUAK1 SUPT5H FOXO4 RPRD2 TAF4 PRKAG2 MAML3 CNOT2 MED13 ZNF577 CPSF6 MAMLD1 CREBBP TRIM33 KMT2D EAF1 TRIM28 TP63 SMARCA4 ZFHX3 TCF7L1 EP300 | 2.41e-04 | 1387 | 170 | 32 | M734 |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.45e-04 | 47 | 170 | 5 | M7946 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 2.48e-04 | 26 | 170 | 4 | M32 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.71e-04 | 48 | 170 | 5 | M288 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.99e-04 | 49 | 170 | 5 | M618 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.06e-04 | 76 | 170 | 6 | MM15520 | |
| Pathway | WP_THERMOGENESIS | 3.29e-04 | 108 | 170 | 7 | M39746 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.33e-04 | 28 | 170 | 4 | M6177 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.68e-04 | 110 | 170 | 7 | M48259 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | KDM3A ARID1A KMT2C ARID1B SAP130 EP400 CREBBP KMT2D SMARCA4 DOT1L EP300 | 4.64e-04 | 272 | 170 | 11 | M29619 |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.69e-04 | 14 | 170 | 3 | M27402 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 6.36e-04 | 33 | 170 | 4 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 6.57e-04 | 58 | 170 | 5 | M29616 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.59e-04 | 158 | 170 | 8 | MM14791 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 7.05e-04 | 15 | 170 | 3 | M48323 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 7.98e-04 | 35 | 170 | 4 | M47969 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 8.60e-04 | 16 | 170 | 3 | M27410 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 8.60e-04 | 16 | 170 | 3 | M27940 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 9.88e-04 | 37 | 170 | 4 | M27797 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | NCOA6 ARID1A KMT2C ARID1B SAP130 TET3 KMT2D TRIM28 SMARCA4 EP300 | 1.03e-03 | 254 | 170 | 10 | M27131 |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.03e-03 | 17 | 170 | 3 | M48025 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 1.03e-03 | 17 | 170 | 3 | M27189 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.03e-03 | 17 | 170 | 3 | M27412 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.23e-03 | 18 | 170 | 3 | M26942 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.41e-03 | 5 | 170 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.41e-03 | 5 | 170 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.41e-03 | 5 | 170 | 2 | MM1575 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.41e-03 | 5 | 170 | 2 | M27228 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.45e-03 | 19 | 170 | 3 | M18933 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.45e-03 | 69 | 170 | 5 | M46439 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 1.67e-03 | 142 | 170 | 7 | M39575 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.95e-03 | 21 | 170 | 3 | MM15706 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.95e-03 | 21 | 170 | 3 | M27485 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.95e-03 | 21 | 170 | 3 | M39593 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.07e-03 | 45 | 170 | 4 | M39571 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.08e-03 | 233 | 170 | 9 | M27099 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.10e-03 | 6 | 170 | 2 | M22062 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.25e-03 | 46 | 170 | 4 | MM15971 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZNF384 SYNRG NCOA6 RAPGEF6 ABL1 PCNX3 PPRC1 TMEM94 MAML1 MED14 FAM110A ZNF395 BCL9 SRCAP ARID1A CIC HIRA C2CD2L SCAF1 KMT2C NUAK1 PI4KA RIPOR1 HERC1 ZC3H7B HOXB13 MED13 PRRC2B PHLDB3 HSPG2 CRYBG2 EP400 ZBTB4 AKNA RELB ECE1 POM121C DENND1A KMT2D SHANK2 MAP1S TRIM28 CSPG4 LRP3 AKAP13 HMGXB3 SLC45A1 DOT1L SSBP4 MBD5 PUM1 GGA1 EP300 ATPAF2 | 3.29e-29 | 1105 | 251 | 54 | 35748872 |
| Pubmed | BCL9L IRF2BP2 NCOA3 NCOA6 NACA BCORL1 GATA1 MAML1 ZMYM2 KLF3 BCL11A BCL9 SRCAP SSBP3 ARID1A SPATA2 LARP4 CIC HIRA TLX1 KMT2C ARID1B BBX SATB1 ATXN2 RPRD2 TAF4 HERC1 SAP130 CNOT2 PRRC2B HSPG2 EP400 MRPS18B PUM2 RELB MAP7 RFX7 POM121C CREBBP LHX1 TRIM33 MAP7D1 KMT2D RBM12 NKX2-4 TLE1 TLE3 YLPM1 SMARCA4 ZFHX3 EIF3F DOT1L SSBP4 PUM1 EP300 | 1.57e-25 | 1429 | 251 | 56 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L IRF2BP2 NCOA3 NCOA6 MAML1 BCL9 ARID1A LARP4 CIC KMT2C ARID1B POM121 ATXN2 NIT1 SAP130 MAML3 CNOT2 PRRC2B CPSF6 MAMLD1 PUM2 POM121C CREBBP TRIM33 KMT2D RBM12 TLE1 TLE3 YLPM1 NUP133 PUM1 EP300 | 4.52e-22 | 457 | 251 | 32 | 32344865 |
| Pubmed | IRF2BP2 NCOA3 ZNF384 NCOA6 ZMYM2 BCL9 ARID1A CIC ARID1B SATB1 SAP130 EP400 KMT2D TLE1 TLE3 TP63 SMARCA4 EP300 | 7.50e-22 | 83 | 251 | 18 | 28794006 | |
| Pubmed | BCL9L IRF2BP2 NCOA3 NCOA6 MAML1 MED14 ZMYM2 BCL9 ARID1A CIC HIRA ARID1B RPRD2 SAP130 MED13 PRRC2B EP400 CPSF6 CREBBP TRIM33 KMT2D RBM12 TLE1 TLE3 YLPM1 SMARCA4 | 1.15e-21 | 268 | 251 | 26 | 33640491 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA3 NCOA6 BCORL1 MAML1 ZMYM2 KLF3 BCL11A BCL9 ARID1A HIRA KMT2C ARID1B SATB1 TAF4 PRRC2B EP400 TPRX2 RFX7 POM121C CREBBP TRIM33 KMT2D TLE1 TLE3 SMARCA4 ZFHX3 EP300 | 6.15e-21 | 351 | 251 | 28 | 38297188 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 KIF1A ZNF189 DAB1 RBBP8NL SSBP3 ARID1A LARP4 KMT2C TMEM184A SLC35A4 ATXN2 AFF1 RIPOR1 RPRD2 TAF4 SPATS2 PRKAG2 SAP130 TET3 MAML3 THRAP3 NPAS2 GULP1 EP400P1 ZDHHC14 DENND1A CREBBP SGK2 PACS1 SHANK2 TLE3 KIAA1217 RASGEF1C ZFHX2 AKAP13 ZFHX3 IGSF9B MBD5 EP300 VPS13B PDZD2 | 3.73e-14 | 1489 | 251 | 42 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 NCOA3 KDM3A SYNRG NCOA6 RAPGEF6 MED14 ZMYM2 BCL9 CTTNBP2NL CIC SCAF1 WWC2 FBXO4 AFF1 RIPOR1 BAG6 THRAP3 MED13 EP400 PUM2 RFX7 PACS1 KMT2D MAP1S TRIM28 TLE3 YLPM1 SMARCA4 PHLDB2 | 8.98e-14 | 774 | 251 | 30 | 15302935 |
| Pubmed | 1.33e-13 | 6 | 251 | 6 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.33e-13 | 6 | 251 | 6 | 25930072 | |
| Pubmed | BCL9L PCNX3 KIF1A NACA MAML1 MED14 ZMYM2 FAM110A UNC45A SSBP3 CTTNBP2NL CIC HIRA C2CD2L SCAF1 KMT2C BBX ATXN2 PI4KA FBXO28 CIZ1 TAF4 SPATS2 ZC3H7B CNOT2 MED13 USP30 EP400 CPSF6 MRPS18B PUM2 MAP7 RAB11FIP1 DENND1A TRIM33 GORASP2 MAP7D1 SHANK2 ZFHX3 EIF3F CTNND2 | 2.04e-13 | 1497 | 251 | 41 | 31527615 | |
| Pubmed | NCOA3 MAML1 BCL9 SSBP3 SPATA2 CIC SCNM1 CIZ1 PRRC2B CPSF6 PUM2 RFX7 CREBBP RBM12 EP300 | 4.10e-13 | 152 | 251 | 15 | 38360978 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NCOA3 ZNF384 PATZ1 GATA1 E2F7 EVX1 ZNF395 CIC RXRB TLX1 BBX SATB1 FOXO4 HOXB13 ZNF541 EBF4 NPAS2 SOX30 ZBTB4 AKNA RELB RFX7 CREB3L1 KMT2D NKX2-4 TP63 ZFHX2 ZFHX3 TOX2 TCF7L1 PROX1 | 9.36e-13 | 908 | 251 | 31 | 19274049 |
| Pubmed | IRF2BP2 NCOA3 KDM3A ZNF384 NCOA6 BCORL1 GATA1 MAML1 MED14 ZMYM2 BCL11A BCL9 ARID1A CIC KMT2C ARID1B ATXN2 TAF4 SAP130 BAG6 THRAP3 PRRC2B RAD23A EP400 CPSF6 CREBBP TRIM33 CUTA MAP7D1 KMT2D RBM12 TLE3 SMARCA4 EP300 | 1.17e-12 | 1103 | 251 | 34 | 34189442 | |
| Pubmed | KDM3A SYNRG NCOA6 RAPGEF6 MED14 UNC45A SRCAP ARID1A KMT2C ARID1B CIZ1 RPRD2 TAF4 SAP130 THRAP3 PRRC2B EP400 CREBBP KMT2D TRIM28 YLPM1 SMARCA4 DOT1L EP300 | 2.55e-12 | 549 | 251 | 24 | 38280479 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NCOA3 ZNF384 ZBTB22 GATA1 MAML1 ZMYM2 SSBP3 CIC RXRB TLX1 SUPT5H MAML3 CNOT2 HOXB13 EBF4 NPAS2 SALL4 RELB RUNX1T1 CREBBP CREB3L1 LHX1 TRIM28 TLE1 TP63 HMGXB3 SSBP4 EP300 PROX1 | 1.16e-11 | 877 | 251 | 29 | 20211142 |
| Pubmed | NCOA3 PATZ1 ZBTB22 SH3BP1 ZMYM2 BCL11A BCL9 HIRA ATXN2 PI4KA TAF4 SPATS2 THRAP3 PRRC2B AGAP2 ANK2 PRR36 FRY MAP7D1 TRIM67 SHANK2 TRIM28 KIAA1217 YLPM1 SMARCA4 PRKCG CTNND2 TNS1 PHLDB2 PROX1 | 2.15e-11 | 963 | 251 | 30 | 28671696 | |
| Pubmed | RALGAPA1 KDM3A NCOA6 NACA MAML1 SH3GLB2 CTTNBP2NL KMT2C ARID1B NUAK1 RPRD2 CACNA1G ZC3H7B ARHGAP20 MED13 EP400 FBF1 AKNA TRIM33 RBM12 HMGXB3 RIMS2 | 5.64e-11 | 529 | 251 | 22 | 14621295 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZNF384 NCOA6 MED14 ZMYM2 UNC45A SRCAP ARID1A HIRA ARID1B SAP130 THRAP3 CNOT2 EP400 CPSF6 POM121C KMT2D TLE3 YLPM1 | 7.44e-11 | 341 | 251 | 18 | 32971831 |
| Pubmed | KIF1A ZBTB22 GATA1 KLF3 BCL11A ARID1A CIC RXRB KMT2C SATB1 FOXO4 MAML3 CNOT2 HOXB13 RELB CREBBP LHX1 TRIM28 SMARCA4 ZFHX2 ZFHX3 HMGXB3 EIF3F TCF7L1 PROX1 | 8.73e-11 | 709 | 251 | 25 | 22988430 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 BCORL1 MAML1 E2F7 ARID1A KMT2C ARID1B SUPT5H CIZ1 EP400 PCLO CREBBP TRIM33 KMT2D TLE1 TLE3 SMARCA4 DOT1L EP300 | 1.21e-10 | 398 | 251 | 19 | 35016035 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PATZ1 MAML1 ZMYM2 CIC RXRB HIRA ACSL4 BBX SATB1 PI4KA FOXO4 SAP130 THRAP3 HOXB13 EP400 RELB RUNX1T1 CREBBP TRIM33 MAP7D1 KMT2D TLE1 TLE3 NUP133 SMARCA4 PUM1 EP300 | 1.82e-10 | 857 | 251 | 27 | 25609649 |
| Pubmed | IRF2BP2 NCOA3 NCOA6 LRRC37A3 BCORL1 MAML1 ZMYM2 BCL9 ARID1A CIC ACSL4 ARID1B MAML3 CAVIN2 PRRC2B FBF1 MUC16 POM121C CREBBP KMT2D TLE3 CTNND2 EP300 | 3.35e-10 | 638 | 251 | 23 | 31182584 | |
| Pubmed | PPRC1 TMEM94 BCL11A SPATA2 ARHGEF17 C2CD2L FBXO28 RIPOR1 TET3 PRRC2B EP400 PUM2 MAP7D1 TLE3 DAAM2 PUM1 VPS13B PDZD2 | 1.27e-09 | 407 | 251 | 18 | 12693553 | |
| Pubmed | BCL9L PPRC1 NACA MED14 SH3GLB2 FAM110A UNC45A POM121 PI4KA RIPOR1 CACNA1G EP400 CPSF6 RAB11FIP1 ECE1 CREBBP LHX1 TRIM33 H1-3 SMARCA4 PUM1 RIMS2 EP300 INPP5J | 1.62e-09 | 754 | 251 | 24 | 35906200 | |
| Pubmed | BCL9L NCOA3 ARID1A KMT2C SUPT5H RTL9 BAG6 CEP97 CRYBG2 EP400 CPSF6 SALL4 TRIM33 KMT2D TRIM28 H1-3 NUP133 SMARCA4 EIF3F | 1.86e-09 | 469 | 251 | 19 | 27634302 | |
| Pubmed | NCOA6 ZMYM2 UNC45A ARID1B ZFYVE9 SUPT5H AFF1 NID1 NIT1 HERC1 SAP130 BAG6 HSPG2 CREBBP KMT2D CSPG4 YLPM1 EIF3F ASB2 PUM1 GGA1 | 2.62e-09 | 591 | 251 | 21 | 15231748 | |
| Pubmed | 2.65e-09 | 4 | 251 | 4 | 28398509 | ||
| Pubmed | PATZ1 BCL11A SRCAP ARID1A C2CD2L SCAF1 ARID1B RTL9 CIZ1 TAF4 SAP130 PRRC2B EP400P1 EP400 FBF1 MAP7 RAB11FIP1 POM121C CREBBP TRIM33 MAP7D1 EAF1 TRIM28 SMARCA4 ZFHX3 TCF7L1 EP300 PHLDB2 PROX1 | 3.07e-09 | 1116 | 251 | 29 | 31753913 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | NCOA3 MED14 ZMYM2 ARID1A KMT2C TAF4 MED13 EP400 SALL4 TRIM33 KMT2D SMARCA4 | 3.75e-09 | 167 | 251 | 12 | 20362541 |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 4.60e-09 | 10 | 251 | 5 | 16751102 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 SYNRG NCOA6 RAPGEF6 ABL1 PATZ1 UNC45A ARHGEF17 CIC WWC2 PI4KA SYDE2 FOXO4 WNK4 MAP7 RAB11FIP1 RFX7 DENND1A PABIR2 MAP7D1 KIAA1217 AKAP13 PRKCG PUM1 PHLDB2 | 4.61e-09 | 861 | 251 | 25 | 36931259 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | IRF2BP2 KDM3A SYNRG ZMYM2 LARP4 CTTNBP2NL HIRA SATB1 TAF4 CEP97 EP400 MAMLD1 CREBBP TRIM33 RBM12 TRIM28 TLE3 EIF3F | 4.96e-09 | 444 | 251 | 18 | 34795231 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 PATZ1 BCORL1 ZMYM2 ZNF395 SRCAP ARID1A CIC HIRA SCAF1 KMT2C BBX SUPT5H FBXO28 CIZ1 RPRD2 TAF4 SAP130 TET3 THRAP3 EP400 MAP7 RFX7 POM121C MAP7D1 KMT2D TRIM28 YLPM1 NUP133 SMARCA4 EP300 | 5.67e-09 | 1294 | 251 | 31 | 30804502 |
| Pubmed | 8.39e-09 | 11 | 251 | 5 | 18003620 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA3 ARID1A KMT2C ARID1B THRAP3 HOXB13 TRIM33 KMT2D RBM12 TRIM28 YLPM1 ZFHX3 EP300 | 8.91e-09 | 220 | 251 | 13 | 35785414 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | PATZ1 ZMYM2 ARID1A HIRA KMT2C SAP130 EP400 PUM2 SALL4 KIAA1217 PUM1 | 1.03e-08 | 146 | 251 | 11 | 23892456 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NCOA3 SYNRG RAPGEF6 RIPK1 MAML1 SPATA2 WWC2 RIPOR1 RPRD2 SPATS2 CEP97 THRAP3 CNOT2 SCHIP1 TEPSIN CPSF6 APBA3 RELB RAB11FIP1 DENND1A PABIR2 TRIM33 GORASP2 EAF1 SHANK2 KIAA1217 PUM1 | 1.09e-08 | 1038 | 251 | 27 | 26673895 |
| Pubmed | 1.21e-08 | 23 | 251 | 6 | 9225980 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.43e-08 | 40 | 251 | 7 | 34585037 | |
| Pubmed | 1.61e-08 | 24 | 251 | 6 | 32212159 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 RAPGEF6 BCL9 CIC POM121 ATXN2 AFF1 SAP130 WNK4 EP400 RELB POM121C MAP1S TP63 YLPM1 AKAP13 IGSF9B | 1.93e-08 | 430 | 251 | 17 | 35044719 |
| Pubmed | NCOA3 PATZ1 ZBTB22 GATA1 ZMYM2 KLF3 SRCAP ARID1A CIC RXRB BBX SATB1 CIZ1 CNOT2 NPAS2 ZDHHC14 SALL4 NKX2-4 TRIM28 TLE3 ZFHX3 HMGXB3 TCF7L1 | 2.83e-08 | 808 | 251 | 23 | 20412781 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 ZNF384 SYNRG RAPGEF6 NACA ZMYM2 UNC45A SRCAP CIC CIZ1 RPRD2 PRRC2B ANK2 EP400 CPSF6 PUM2 POM121C GORASP2 RBM12 TRIM28 KIAA1217 YLPM1 NUP133 SMARCA4 | 9.40e-08 | 934 | 251 | 24 | 33916271 |
| Pubmed | BCL9L NCOA3 NCOA6 NACA BCORL1 MAML1 BCL9 ARID1A CIC TAF4 BAG6 PCLO CREBBP TRIM33 H1-3 EP300 | 9.96e-08 | 425 | 251 | 16 | 24999758 | |
| Pubmed | 9.98e-08 | 78 | 251 | 8 | 28611094 | ||
| Pubmed | 1.42e-07 | 55 | 251 | 7 | 18570454 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 1.49e-07 | 18 | 251 | 5 | 28068325 | |
| Pubmed | 1.51e-07 | 34 | 251 | 6 | 30894540 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | ZMYM2 SRCAP ARID1A ARID1B SUPT5H TAF4 SAP130 EP400 SMARCA4 CSNK2A3 | 1.55e-07 | 150 | 251 | 10 | 28242625 |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 1.81e-07 | 8 | 251 | 4 | 28296634 | |
| Pubmed | 1.82e-07 | 57 | 251 | 7 | 18022353 | ||
| Pubmed | PATZ1 NACA BCORL1 SSBP3 ARID1B SAP130 BAG6 EP400 PCLO MUC16 SALL4 TRIM33 MAP7D1 H1-3 TCF7L1 | 2.33e-07 | 396 | 251 | 15 | 26687479 | |
| Pubmed | KDM3A NCOA6 SRCAP ARID1A ARID1B EP400 CREBBP KMT2D SMARCA4 EP300 | 2.37e-07 | 157 | 251 | 10 | 30186101 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG BCORL1 MAML1 E2F7 ZMYM2 SH3GLB2 SRCAP ARID1A CIC SUPT5H PI4KA PRRC2B EP400 MAP7 CREBBP TRIM33 KIAA1217 DOT1L | 3.38e-07 | 588 | 251 | 18 | 38580884 |
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 27903646 | ||
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 10347196 | ||
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 3.71e-07 | 3 | 251 | 3 | 12050117 | |
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 3.71e-07 | 3 | 251 | 3 | 11823864 | |
| Pubmed | 3.71e-07 | 3 | 251 | 3 | 9590171 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 3.71e-07 | 3 | 251 | 3 | 22426308 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L PATZ1 SSBP3 SCAF1 THRAP3 PRRC2B FBF1 MAP7 ECE1 MAP7D1 MAP1S AKAP13 CTNND2 PHLDB2 | 4.47e-07 | 361 | 251 | 14 | 26167880 |
| Pubmed | 5.08e-07 | 66 | 251 | 7 | 23275444 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZNF384 ZBTB22 GATA1 E2F7 KLF3 EVX1 RXRB BBX FOXO4 HOXB13 NPAS2 SOX30 RFX7 CREB3L1 LHX1 TCF7L1 PROX1 | 5.45e-07 | 544 | 251 | 17 | 28473536 |
| Pubmed | CIC SCAF1 POM121 ATXN2 CACNA1G NIT1 ZC3H7B BAG6 PRRC2B RAD23A HSPG2 CPSF6 RUNX1T1 GORASP2 MAP7D1 HSFX1 PRKCG PUM1 | 5.48e-07 | 608 | 251 | 18 | 16713569 | |
| Pubmed | CDCA3 UNC45A ARID1A POM121 ATXN2 PRRC2B POM121C GORASP2 KIAA1217 TENM1 NUP133 VPS13B | 5.51e-07 | 263 | 251 | 12 | 34702444 | |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 5.69e-07 | 23 | 251 | 5 | 10235267 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 6.13e-07 | 134 | 251 | 9 | 25452129 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | IRF2BP2 ZNF384 ZMYM2 ARID1A HIRA SATB1 SUPT5H CREBBP SMARCA4 EP300 | 7.55e-07 | 178 | 251 | 10 | 27637333 |
| Pubmed | RALGAPA1 CDCA3 ARID1A CIC ACSL4 WWC2 ARID1B ZFYVE9 ATXN2 SUPT5H PI4KA HERC1 PRRC2B DUSP8 RAB11FIP1 PABIR2 PACS1 GORASP2 KMT2D TLE3 YLPM1 NUP133 PUM1 TNS1 | 7.57e-07 | 1049 | 251 | 24 | 27880917 | |
| Pubmed | KDM3A KIF1A PPRC1 ZNF189 ZMYM2 SH3GLB2 ARID1A SATB1 SUPT5H CNOT2 MED13 AGAP2 ANK2 ZBTB4 APBA1 CREBBP TRIM33 FRY GORASP2 MAP1S YLPM1 SMARCA4 DAAM2 EIF3F CTNND2 REPS2 EP300 | 7.74e-07 | 1285 | 251 | 27 | 35914814 | |
| Pubmed | 8.40e-07 | 11 | 251 | 4 | 24038357 | ||
| Pubmed | KIF1A TMEM94 MED14 LARP4 BBX SUPT5H HERC1 SCHIP1 ANK2 RUNX1T1 CREB3L1 MAP7D1 SHANK2 NUP133 CTNND2 RIMS2 ATPAF2 | 9.84e-07 | 568 | 251 | 17 | 9110174 | |
| Pubmed | 1.00e-06 | 105 | 251 | 8 | 9628581 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | KIF1A TMEM94 MED14 LARP4 BBX SUPT5H HERC1 SCHIP1 ANK2 RUNX1T1 CREB3L1 MAP7D1 SHANK2 NUP133 CTNND2 RIMS2 ATPAF2 | 1.13e-06 | 574 | 251 | 17 | 8619474 |
| Pubmed | 1.16e-06 | 107 | 251 | 8 | 11347906 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.25e-06 | 12 | 251 | 4 | 14645221 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NCOA3 PATZ1 MAML1 FAM110A POM121 BBX SUPT5H RTL9 CIZ1 RIPOR1 CEP97 CNOT2 PRRC2B PHLDB3 CPSF6 MAP7 RAB11FIP1 POM121C DENND1A CREBBP PABIR2 PACS1 GORASP2 EAF1 NUP133 GGA1 PHLDB2 | 1.31e-06 | 1321 | 251 | 27 | 27173435 |
| Pubmed | IRF2BP2 KDM3A BCORL1 MAML1 ZMYM2 ARID1B BBX RPRD2 SAP130 EP400 TRIM33 TLE3 SMARCA4 | 1.31e-06 | 339 | 251 | 13 | 30415952 | |
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 22207202 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 1.48e-06 | 4 | 251 | 3 | 10655477 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 1.48e-06 | 4 | 251 | 3 | 11988099 | |
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 25679763 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 25911675 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 9194565 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 34645806 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 16227615 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 11581372 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 11196199 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 22419166 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 11701890 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 33589584 | ||
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 1.48e-06 | 4 | 251 | 3 | 15170388 | |
| Pubmed | 1.61e-06 | 28 | 251 | 5 | 30037996 | ||
| Pubmed | RALGAPA1 TMEM94 NACA MAML1 LARP4 C2CD2L GJA1 ARID1B RPRD2 CNOT2 PHLDB3 EP400 PUM2 GORASP2 TLE1 YLPM1 SMARCA4 AKAP13 PUM1 | 1.90e-06 | 733 | 251 | 19 | 34672954 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | PATZ1 ZMYM2 ARID1A THRAP3 EP400 PUM2 SALL4 RUNX1T1 TRIM33 MAP7D1 TRIM28 YLPM1 SMARCA4 EP300 | 2.06e-06 | 411 | 251 | 14 | 35182466 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.30e-06 | 157 | 251 | 9 | 30686591 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | NACA ZMYM2 ARID1A SAP130 PRRC2B HSPG2 CPSF6 SALL4 SMARCA4 TOX2 | 2.48e-06 | 203 | 251 | 10 | 22083510 |
| Pubmed | 2.50e-06 | 14 | 251 | 4 | 12482968 | ||
| Interaction | NUP35 interactions | BCL9L IRF2BP2 NCOA3 NCOA6 MAML1 BCL9 ARID1A LARP4 CIC KMT2C ARID1B POM121 ATXN2 NIT1 SAP130 MAML3 CNOT2 PRRC2B CPSF6 MAMLD1 PUM2 POM121C CREBBP TRIM33 KMT2D RBM12 TRIM67 TRIM28 TLE1 TLE3 YLPM1 NUP133 PUM1 EP300 PDZD2 | 3.72e-19 | 424 | 247 | 35 | int:NUP35 |
| Interaction | TOP3B interactions | ZNF384 SYNRG NCOA6 RAPGEF6 ABL1 PCNX3 PPRC1 TMEM94 MAML1 MED14 FAM110A ZNF395 UNC45A BCL9 SRCAP ARID1A LARP4 CIC HIRA C2CD2L SCAF1 KMT2C NUAK1 ATXN2 PI4KA RIPOR1 HERC1 ZC3H7B CNOT2 HOXB13 MED13 PRRC2B PHLDB3 HSPG2 CRYBG2 EP400 ZBTB4 APBA1 AKNA RELB ECE1 POM121C DENND1A GORASP2 KMT2D SHANK2 MAP1S TRIM28 CSPG4 LRP3 AKAP13 HMGXB3 SLC45A1 DOT1L SSBP4 MBD5 PUM1 GGA1 EP300 ATPAF2 | 5.11e-17 | 1470 | 247 | 60 | int:TOP3B |
| Interaction | TBXT interactions | IRF2BP2 NCOA3 NCOA6 MAML1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 SAP130 CREBBP KMT2D TLE1 TLE3 SMARCA4 DOT1L EP300 | 2.40e-16 | 116 | 247 | 19 | int:TBXT |
| Interaction | SP7 interactions | BCL9L IRF2BP2 NCOA3 NCOA6 MAML1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 RPRD2 SAP130 PRRC2B EP400 CREBBP TRIM33 KMT2D RBM12 NKX2-4 TLE1 TLE3 YLPM1 SMARCA4 EP300 | 7.84e-15 | 304 | 247 | 26 | int:SP7 |
| Interaction | PAX7 interactions | NCOA3 MAML1 BCL9 SSBP3 ARID1A CIC HIRA KMT2C ARID1B SATB1 SAP130 CREBBP KMT2D TLE1 TLE3 ZFHX3 SSBP4 EP300 | 1.35e-14 | 124 | 247 | 18 | int:PAX7 |
| Interaction | TLE3 interactions | BCL9L IRF2BP2 NCOA3 KDM3A BCORL1 GATA1 MAML1 KLF3 BCL9 ARID1A CIC TLX1 ARID1B POM121 TAF4 SAP130 ZBTB4 TPRX2 CREBBP KMT2D RBM12 TLE1 TLE3 SMARCA4 ZFHX3 DOT1L SSBP4 EP300 | 2.29e-14 | 376 | 247 | 28 | int:TLE3 |
| Interaction | EGR2 interactions | BCL9L NCOA3 NCOA6 BCORL1 MAML1 BCL11A BCL9 ARID1A HIRA KMT2C ARID1B PRRC2B EP400 CREBBP TRIM33 KMT2D TLE1 TLE3 ZFHX3 EP300 | 3.09e-14 | 171 | 247 | 20 | int:EGR2 |
| Interaction | PAX9 interactions | BCL9L NCOA3 NCOA6 MAML1 BCL11A BCL9 ARID1A CIC KMT2C ARID1B SATB1 SAP130 TEPSIN KMT2D TLE1 TLE3 ZFHX3 EP300 | 3.16e-14 | 130 | 247 | 18 | int:PAX9 |
| Interaction | SOX9 interactions | NCOA3 NCOA6 BCL9 ARID1A CIC KMT2C ARID1B HERC1 EP400 CREBBP KMT2D TRIM67 TLE1 TLE3 SMARCA4 EP300 | 5.22e-14 | 97 | 247 | 16 | int:SOX9 |
| Interaction | AR interactions | BCL9L IRF2BP2 NCOA3 KDM3A NCOA6 ABL1 KIF1A PATZ1 MAML1 MED14 ZMYM2 DCC BCL9 SRCAP ARID1A CIC HIRA KMT2C ARID1B RPRD2 SAP130 BAG6 THRAP3 HOXB13 MED13 PRRC2B EP400 CPSF6 RAB11FIP1 CREBBP TRIM33 KMT2D RBM12 TRIM28 TLE1 TLE3 KIAA1217 YLPM1 SMARCA4 ZFHX3 DOT1L REPS2 TNS1 EP300 | 9.33e-14 | 992 | 247 | 44 | int:AR |
| Interaction | NFIB interactions | IRF2BP2 NCOA3 MAML1 KLF3 BCL9 SSBP3 ARID1A CIC TLX1 KMT2C ARID1B CREBBP LHX1 KMT2D NKX2-4 TLE1 TLE3 DOT1L | 1.52e-13 | 142 | 247 | 18 | int:NFIB |
| Interaction | TLX1 interactions | IRF2BP2 NCOA3 MAML1 BCL9 SSBP3 ARID1A CIC TLX1 KMT2C ARID1B SATB1 SAP130 MRPS18B CREBBP KMT2D TLE1 TLE3 ZFHX3 EP300 | 5.40e-13 | 175 | 247 | 19 | int:TLX1 |
| Interaction | FEV interactions | NCOA3 NCOA6 MAML1 BCL11A BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 TAF4 PRRC2B EP400 CREBBP KMT2D TLE1 TLE3 ZFHX3 EP300 | 8.16e-13 | 203 | 247 | 20 | int:FEV |
| Interaction | SOX7 interactions | NCOA3 BCORL1 MAML1 ARID1A KMT2C ARID1B CREBBP TRIM33 KMT2D TLE1 TLE3 SMARCA4 DOT1L EP300 | 1.25e-12 | 82 | 247 | 14 | int:SOX7 |
| Interaction | HNF1B interactions | NCOA3 MAML1 BCL9 ARID1A CIC HIRA KMT2C ARID1B SATB1 SAP130 THRAP3 PRRC2B EP400 CREBBP KMT2D TLE1 TLE3 ZFHX3 EP300 | 2.38e-12 | 190 | 247 | 19 | int:HNF1B |
| Interaction | CRX interactions | BCL9L NCOA3 BCORL1 MAML1 BCL9 ARID1A LARP4 HIRA KMT2C ARID1B MYO15B PRRC2B NPAS2 EP400 CREBBP TRIM33 KMT2D TLE1 TLE3 ZFHX3 EP300 | 6.47e-12 | 254 | 247 | 21 | int:CRX |
| Interaction | PAX8 interactions | NCOA3 MAML1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B PRRC2B CREBBP KMT2D NKX2-4 TLE1 TLE3 EP300 | 6.60e-12 | 111 | 247 | 15 | int:PAX8 |
| Interaction | TBR1 interactions | BCL9L NCOA3 MAML1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B KMT2D NKX2-4 TLE1 TLE3 ZFHX3 EP300 | 8.60e-12 | 113 | 247 | 15 | int:TBR1 |
| Interaction | PAX6 interactions | IRF2BP2 NCOA3 NCOA6 ZMYM2 BCL9 SRCAP ARID1A LARP4 CIC KMT2C ARID1B SATB1 SAP130 PRRC2B EP400 CREBBP KMT2D EAF1 TLE1 TLE3 SMARCA4 ZFHX3 EP300 PROX1 | 2.66e-11 | 366 | 247 | 24 | int:PAX6 |
| Interaction | HNF4A interactions | IRF2BP2 NCOA3 NCOA6 MED14 ZMYM2 SRCAP ARID1A CIC HIRA KMT2C ARID1B TAF4 SAP130 EP400 CREBBP TRIM33 KMT2D TLE1 SMARCA4 EP300 PROX1 | 2.92e-11 | 275 | 247 | 21 | int:HNF4A |
| Interaction | IRF4 interactions | NCOA3 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 HOXB13 PRRC2B KMT2D TLE1 EP300 PROX1 | 3.47e-11 | 85 | 247 | 13 | int:IRF4 |
| Interaction | GCM1 interactions | NCOA3 BCL9 ARID1A CIC KMT2C ARID1B PRRC2B CREBBP KMT2D TLE1 TLE3 EP300 | 3.49e-11 | 68 | 247 | 12 | int:GCM1 |
| Interaction | GSC interactions | BCL9L NCOA3 BCORL1 BCL11A BCL9 KMT2C ARID1B CREBBP KMT2D TLE1 TLE3 ZFHX3 EP300 | 4.70e-11 | 87 | 247 | 13 | int:GSC |
| Interaction | GATA2 interactions | NCOA3 NCOA6 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 SAP130 PRRC2B CREBBP KMT2D TLE1 TLE3 SMARCA4 ZFHX3 EP300 | 4.95e-11 | 199 | 247 | 18 | int:GATA2 |
| Interaction | KLF5 interactions | NCOA3 NCOA6 MAML1 BCL9 ARID1A CIC KMT2C ARID1B PRRC2B EP400 MRPS18B CREBBP KMT2D TLE1 TLE3 TP63 EP300 | 3.08e-10 | 195 | 247 | 17 | int:KLF5 |
| Interaction | SMG7 interactions | IRF2BP2 NCOA3 NCOA6 MAML1 BCL9 ARID1A ARID1B ATXN2 RPRD2 CEP97 CNOT2 PRRC2B CPSF6 CREBBP KMT2D RBM12 TLE1 TLE3 YLPM1 DOT1L PUM1 | 4.57e-10 | 319 | 247 | 21 | int:SMG7 |
| Interaction | KLF3 interactions | IRF2BP2 BCORL1 ZMYM2 KLF3 BCL11A ARID1A CIC HIRA ARID1B TAF4 SAP130 EP400 RFX7 KMT2D TLE1 TLE3 ZFHX3 EP300 | 4.63e-10 | 228 | 247 | 18 | int:KLF3 |
| Interaction | EYA4 interactions | NCOA3 MAML1 BCL9 SSBP3 SPATA2 CIC TLX1 SCNM1 SUPT5H CIZ1 PRRC2B CPSF6 PUM2 RFX7 CREBBP RBM12 TRIM67 EP300 | 1.29e-09 | 243 | 247 | 18 | int:EYA4 |
| Interaction | FOXI1 interactions | NCOA3 BCL9 ARID1A KMT2C ARID1B SATB1 CREBBP TRIM33 KMT2D TLE1 TLE3 EP300 | 1.34e-09 | 92 | 247 | 12 | int:FOXI1 |
| Interaction | LDB1 interactions | BCL9L IRF2BP2 GATA1 BCL9 SSBP3 CIC TLX1 LHX1 TRIM33 TLE3 ZFHX3 SSBP4 EP300 | 1.66e-09 | 115 | 247 | 13 | int:LDB1 |
| Interaction | SOX17 interactions | NCOA3 NCOA6 BCL9 ARID1A CIC KMT2C ARID1B TRIM33 KMT2D NKX2-4 TRIM28 TLE1 | 1.96e-09 | 95 | 247 | 12 | int:SOX17 |
| Interaction | ERG interactions | NCOA3 NCOA6 MAML1 ZMYM2 BCL9 ARID1A CIC KMT2C ARID1B PRRC2B CREBBP TRIM33 KMT2D TLE1 TLE3 SMARCA4 EP300 | 2.44e-09 | 223 | 247 | 17 | int:ERG |
| Interaction | GATA1 interactions | ZBTB22 GATA1 MED14 BCL9 ARID1A ARID1B FBF1 CREBBP KMT2D RBM12 TRIM28 TLE1 TLE3 SMARCA4 EP300 | 3.22e-09 | 171 | 247 | 15 | int:GATA1 |
| Interaction | TEAD1 interactions | IRF2BP2 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 CREBBP KMT2D TLE1 TLE3 TP63 H1-3 ZFHX3 EP300 | 4.78e-09 | 176 | 247 | 15 | int:TEAD1 |
| Interaction | GOLGA2 interactions | NCOA6 SYNPO2L GATA1 SH3GLB2 FAM110A BCL11A SPATA2 CTTNBP2NL CIC RXRB GJA1 POM121 SCNM1 SUPT5H FBXO28 SAP130 TEPSIN FBF1 ZBTB4 GORASP2 KMT2D TRIM67 TLE1 TLE3 KIAA1217 ZFHX3 DOT1L EP300 VPS13B INPP5J | 7.73e-09 | 733 | 247 | 30 | int:GOLGA2 |
| Interaction | LHX2 interactions | BCL9L BCORL1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 EP400 KMT2D TLE1 SMARCA4 ZFHX3 SSBP4 | 8.15e-09 | 183 | 247 | 15 | int:LHX2 |
| Interaction | LHX3 interactions | DCC BCL9 SSBP3 ARID1A CIC HIRA KMT2C ARID1B SCNM1 RUNX1T1 CREBBP LHX1 KMT2D TLE1 SSBP4 | 9.45e-09 | 185 | 247 | 15 | int:LHX3 |
| Interaction | NFIA interactions | IRF2BP2 NCOA3 MAML1 KLF3 BCL9 SSBP3 ARID1A CIC TLX1 ARID1B CREBBP KMT2D TLE1 TLE3 EP300 | 1.18e-08 | 188 | 247 | 15 | int:NFIA |
| Interaction | SMARCC2 interactions | NCOA3 GATA1 SRCAP SSBP3 ARID1A HIRA ARID1B FBXO28 CPSF6 TPRX2 RELB CREBBP TRIM33 TRIM67 TRIM28 TLE3 YLPM1 SMARCA4 DOT1L EP300 | 1.56e-08 | 353 | 247 | 20 | int:SMARCC2 |
| Interaction | LHX4 interactions | BCL9L BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 CEP97 TRIM33 KMT2D TLE1 SMARCA4 SSBP4 | 1.80e-08 | 166 | 247 | 14 | int:LHX4 |
| Interaction | TLX3 interactions | BCL9L NCOA3 NCOA6 MAML1 BCL9 SSBP3 ARID1A CIC KMT2C ARID1B SATB1 MRPS18B KMT2D TLE1 TLE3 ZFHX3 TOX2 EP300 | 2.20e-08 | 291 | 247 | 18 | int:TLX3 |
| Interaction | TPRX2 interactions | 2.47e-08 | 56 | 247 | 9 | int:TPRX2 | |
| Interaction | SOX2 interactions | BCL9L IRF2BP2 NCOA3 ZNF384 NCOA6 PCNX3 PATZ1 MAML1 ZMYM2 KLF3 BCL9 SSBP3 ARID1A CIC HIRA TLX1 GJA1 KMT2C ARID1B SATB1 SUPT5H PI4KA SPATS2 PRKAG2 SAP130 THRAP3 PRRC2B EP400 MRPS18B PUM2 SALL4 TRIM33 KMT2D TRIM28 TLE1 TLE3 TP63 KIAA1217 YLPM1 SMARCA4 ZFHX3 EIF3F EP300 | 3.16e-08 | 1422 | 247 | 43 | int:SOX2 |
| Interaction | ETS1 interactions | NCOA3 SRCAP ARID1A ARID1B EP400 RUNX1T1 CREBBP KMT2D TLE3 SMARCA4 GGA1 EP300 | 3.16e-08 | 121 | 247 | 12 | int:ETS1 |
| Interaction | LHX6 interactions | 3.41e-08 | 58 | 247 | 9 | int:LHX6 | |
| Interaction | SSBP4 interactions | 3.98e-08 | 59 | 247 | 9 | int:SSBP4 | |
| Interaction | TRRAP interactions | IRF2BP2 PPRC1 NACA MED14 ZMYM2 SH3GLB2 FAM110A UNC45A SRCAP POM121 PI4KA RIPOR1 CACNA1G TAF4 MED13 EP400 CPSF6 RAB11FIP1 ECE1 CREBBP CREB3L1 LHX1 TRIM33 TRIM67 TRIM28 H1-3 SMARCA4 DOT1L RIMS2 INPP5J | 4.14e-08 | 790 | 247 | 30 | int:TRRAP |
| Interaction | LHX1 interactions | BCL9 SSBP3 ARID1A KMT2C ARID1B SCNM1 SATB1 LHX1 KMT2D TLE1 SSBP4 | 5.55e-08 | 103 | 247 | 11 | int:LHX1 |
| Interaction | ALG13 interactions | NCOA3 BCL9 ARID1A ARID1B ATXN2 PRRC2B CPSF6 PUM2 KMT2D RBM12 TLE1 TLE3 PUM1 EP300 | 6.19e-08 | 183 | 247 | 14 | int:ALG13 |
| Interaction | FOS interactions | NCOA3 NCOA6 ABL1 NACA BCL9 ARID1A CIC HIRA KMT2C ARID1B SCHIP1 EP400 CREBBP TRIM33 KMT2D TLE1 SMARCA4 EP300 | 6.36e-08 | 312 | 247 | 18 | int:FOS |
| Interaction | ASF1A interactions | IRF2BP2 ZNF384 NCOA6 BCORL1 SRCAP ARID1A HIRA ARID1B SAP130 EP400 TRIM33 KMT2D TRIM67 SMARCA4 DOT1L EP300 | 8.06e-08 | 249 | 247 | 16 | int:ASF1A |
| Interaction | GATA3 interactions | NCOA3 BCL9 ARID1A CIC ARID1B SATB1 PRRC2B CREBBP KMT2D RBM12 TLE1 TLE3 DOT1L EP300 | 8.12e-08 | 187 | 247 | 14 | int:GATA3 |
| Interaction | KLF15 interactions | NCOA3 BCORL1 MAML1 BCL9 CIC KMT2C SCNM1 TAF4 SAP130 PRRC2B EP400 MRPS18B MAP7 CREBBP MAP7D1 KMT2D EP300 | 1.19e-07 | 290 | 247 | 17 | int:KLF15 |
| Interaction | ETV4 interactions | 1.61e-07 | 69 | 247 | 9 | int:ETV4 | |
| Interaction | SOX15 interactions | NCOA3 BCL9 SSBP3 ARID1A CIC ARID1B SATB1 MRPS18B KMT2D TLE1 TLE3 EP300 | 1.74e-07 | 141 | 247 | 12 | int:SOX15 |
| Interaction | SSBP3 interactions | BCL9L IRF2BP2 BCL9 SSBP3 TLX1 SUPT5H LHX1 TRIM33 TRIM28 SMARCA4 SSBP4 | 2.47e-07 | 119 | 247 | 11 | int:SSBP3 |
| Interaction | PIN1 interactions | NCOA3 ZBTB22 DAB1 BCL11A RBBP8NL SSBP3 SUPT5H FOXO4 BAG6 THRAP3 APBA1 TRIM67 MAP1S TRIM28 TLE1 TLE3 TP63 SSBP4 EP300 | 2.87e-07 | 383 | 247 | 19 | int:PIN1 |
| Interaction | ARID1B interactions | NCOA3 GATA1 KLF3 ARID1A TLX1 ARID1B SUPT5H TPRX2 CREBBP LHX1 TRIM33 TLE3 SMARCA4 | 2.97e-07 | 177 | 247 | 13 | int:ARID1B |
| Interaction | SMARCC1 interactions | NCOA3 GATA1 SRCAP ARID1A CIC HIRA TLX1 ARID1B CPSF6 TPRX2 SALL4 RELB CREBBP TRIM33 TRIM67 TRIM28 YLPM1 SMARCA4 EP300 | 2.99e-07 | 384 | 247 | 19 | int:SMARCC1 |
| Interaction | VDR interactions | NCOA3 NCOA6 MED14 RXRB AFF1 FOXO4 THRAP3 MED13 RUNX1T1 CREBBP EP300 | 4.78e-07 | 127 | 247 | 11 | int:VDR |
| Interaction | NANOG interactions | PATZ1 ZMYM2 SSBP3 ARID1A HIRA KMT2C ARID1B SAP130 EP400 MUC16 PUM2 SALL4 RELB TRIM33 TRIM28 KIAA1217 SMARCA4 DOT1L PUM1 TCF7L1 EP300 | 5.52e-07 | 481 | 247 | 21 | int:NANOG |
| Interaction | SOX6 interactions | IRF2BP2 NCOA3 MAML1 SSBP3 CIC HIRA SATB1 TAF4 SAP130 TLE1 TLE3 ZFHX3 | 5.58e-07 | 157 | 247 | 12 | int:SOX6 |
| Interaction | HNF1A interactions | 5.87e-07 | 80 | 247 | 9 | int:HNF1A | |
| Interaction | NCOR1 interactions | IRF2BP2 NCOA3 PATZ1 KLF3 SRCAP TLX1 SUPT5H IL17RA CNOT2 TPRX2 RUNX1T1 CREBBP TRIM33 TRIM28 TLE3 H1-3 SMARCA4 EP300 | 5.99e-07 | 363 | 247 | 18 | int:NCOR1 |
| Interaction | SMARCB1 interactions | GATA1 SRCAP ARID1A HIRA TLX1 KMT2C ARID1B PI4KA CPSF6 TPRX2 SALL4 RELB CREBBP GORASP2 TRIM28 SMARCA4 DOT1L EP300 | 6.23e-07 | 364 | 247 | 18 | int:SMARCB1 |
| Interaction | KLF4 interactions | NCOA3 BCL9 ARID1A KMT2C ARID1B MYO15B MRPS18B CREBBP KMT2D TLE1 SMARCA4 EP300 | 6.83e-07 | 160 | 247 | 12 | int:KLF4 |
| Interaction | KLF8 interactions | NCOA3 BCORL1 ZMYM2 CIC TAF4 SAP130 PRRC2B EP400 MRPS18B MAP7 POM121C CREBBP TRIM33 MAP7D1 KMT2D TP63 EP300 | 7.04e-07 | 329 | 247 | 17 | int:KLF8 |
| Interaction | SUPT5H interactions | MED14 BCL11A SSBP3 ARID1A CIC SCAF1 ARID1B ZFYVE9 SUPT5H RPRD2 MAML3 THRAP3 EP400 CPSF6 KMT2D TRIM67 EIF3F DOT1L EP300 | 7.48e-07 | 408 | 247 | 19 | int:SUPT5H |
| Interaction | MYOD1 interactions | NCOA3 BCL9 ARID1A KMT2C ARID1B EP400 CREBBP TRIM33 KMT2D TLE1 TLE3 SMARCA4 EP300 | 8.47e-07 | 194 | 247 | 13 | int:MYOD1 |
| Interaction | PAX2 interactions | 9.88e-07 | 85 | 247 | 9 | int:PAX2 | |
| Interaction | NCOR2 interactions | IRF2BP2 NCOA3 NCOA6 GATA1 KLF3 TLX1 SUPT5H CNOT2 RUNX1T1 CREBBP LHX1 TLE3 H1-3 SMARCA4 EP300 | 9.92e-07 | 264 | 247 | 15 | int:NCOR2 |
| Interaction | SMARCA4 interactions | GATA1 MAML1 SRCAP SSBP3 ARID1A CIC HIRA ARID1B EP400 TPRX2 SALL4 RELB CREBBP TRIM33 TRIM67 TRIM28 TLE3 SMARCA4 DOT1L EP300 | 1.18e-06 | 462 | 247 | 20 | int:SMARCA4 |
| Interaction | KMT2D interactions | NCOA6 GATA1 KLF3 TLX1 KMT2C SUPT5H TPRX2 CREBBP LHX1 KMT2D TLE3 EP300 | 1.22e-06 | 169 | 247 | 12 | int:KMT2D |
| Interaction | TLX2 interactions | BCL9 ARID1A CIC KMT2C ARID1B SATB1 MRPS18B KMT2D TLE1 TLE3 ZFHX3 | 1.46e-06 | 142 | 247 | 11 | int:TLX2 |
| Interaction | HDAC3 interactions | IRF2BP2 GATA1 ZMYM2 ARID1B SUPT5H IL17RA CNOT2 TPRX2 RUNX1T1 CREBBP EAF1 TRIM67 TRIM28 SMARCA4 EP300 PROX1 | 1.73e-06 | 313 | 247 | 16 | int:HDAC3 |
| Interaction | PYGO2 interactions | 1.83e-06 | 48 | 247 | 7 | int:PYGO2 | |
| Interaction | ELF5 interactions | ZMYM2 ARID1A HIRA KMT2C ARID1B SATB1 SALL4 TRIM33 KMT2D TLE1 EP300 | 2.05e-06 | 147 | 247 | 11 | int:ELF5 |
| Interaction | NFIC interactions | NCOA3 KLF3 ARID1A CIC TLX1 ARID1B SAP130 CREBBP KMT2D TRIM67 TLE1 TLE3 DOT1L | 2.06e-06 | 210 | 247 | 13 | int:NFIC |
| Interaction | SMAD3 interactions | NCOA3 NCOA6 RIPK1 ZMYM2 ARID1A CIC ARID1B ZFYVE9 FOXO4 SAP130 RELB CREBBP TRIM33 TRIM67 SMARCA4 ZFHX3 GGA1 EP300 PROX1 | 2.88e-06 | 447 | 247 | 19 | int:SMAD3 |
| Interaction | POU5F1 interactions | PATZ1 NACA ZMYM2 ARID1A HIRA ARID1B SAP130 BAG6 PRRC2B HSPG2 EP400 CPSF6 MUC16 SALL4 TRIM33 MAP7D1 TRIM28 H1-3 SMARCA4 ZFHX3 TOX2 TCF7L1 | 3.36e-06 | 584 | 247 | 22 | int:POU5F1 |
| Interaction | SATB2 interactions | GATA1 ZMYM2 KLF3 CIC TLX1 SATB1 CRYBG2 TPRX2 LHX1 TRIM67 TP63 | 4.40e-06 | 159 | 247 | 11 | int:SATB2 |
| Interaction | E2F5 interactions | 4.57e-06 | 36 | 247 | 6 | int:E2F5 | |
| Interaction | NFIX interactions | IRF2BP2 SRCAP ARID1A CIC KMT2C ARID1B TAF4 SAP130 EP400 KMT2D TLE1 TLE3 ZFHX3 | 4.86e-06 | 227 | 247 | 13 | int:NFIX |
| Interaction | CREBBP interactions | NCOA3 NCOA6 GATA1 MAML1 ZMYM2 SRCAP ARID1A TLX1 ARID1B FOXO4 NPAS2 RAD23A CPSF6 TPRX2 CREBBP TRIM33 KMT2D TRIM28 TLE3 SMARCA4 EP300 PROX1 | 5.04e-06 | 599 | 247 | 22 | int:CREBBP |
| Interaction | KDM6A interactions | NCOA6 GATA1 KLF3 TLX1 KMT2C TPRX2 CREBBP LHX1 KMT2D TLE1 SMARCA4 | 5.27e-06 | 162 | 247 | 11 | int:KDM6A |
| Interaction | KLF1 interactions | 5.39e-06 | 37 | 247 | 6 | int:KLF1 | |
| Interaction | PPARG interactions | NCOA3 NCOA6 ABL1 KIF1A MED14 RXRB KMT2C ARID1B FBXO4 CREBBP KMT2D TRIM28 SMARCA4 EP300 PROX1 | 6.34e-06 | 307 | 247 | 15 | int:PPARG |
| Interaction | FHL3 interactions | GATA1 SH3GLB2 KLF3 FAM110A POM121 ATXN2 SUPT5H MAP7 POM121C PABIR2 CRYBA2 TRIM33 TRIM28 TMEM108 | 8.49e-06 | 276 | 247 | 14 | int:FHL3 |
| Interaction | ARID1A interactions | GATA1 KLF3 ARID1A TLX1 ARID1B SUPT5H TPRX2 SALL4 CREBBP LHX1 TRIM67 TLE3 SMARCA4 EP300 | 8.49e-06 | 276 | 247 | 14 | int:ARID1A |
| Interaction | NR3C1 interactions | IRF2BP2 NCOA3 NCOA6 LRRC37A3 BCORL1 MAML1 MED14 ZMYM2 BCL9 ARID1A CIC RXRB ACSL4 ARID1B IL17RA MAML3 CAVIN2 PRRC2B FBF1 MUC16 POM121C CREBBP KMT2D TRIM67 TRIM28 TLE3 SMARCA4 CTNND2 EP300 | 9.52e-06 | 974 | 247 | 29 | int:NR3C1 |
| Interaction | FOXQ1 interactions | 9.67e-06 | 141 | 247 | 10 | int:FOXQ1 | |
| Interaction | CEBPA interactions | IRF2BP2 NCOA3 KDM3A ZNF384 NCOA6 BCORL1 GATA1 MAML1 MED14 ZMYM2 BCL11A BCL9 ARID1A CIC KMT2C ARID1B ATXN2 TAF4 SAP130 BAG6 THRAP3 PRRC2B RAD23A EP400 CPSF6 CREBBP TRIM33 CUTA MAP7D1 KMT2D RBM12 TLE3 SMARCA4 EP300 | 9.73e-06 | 1245 | 247 | 34 | int:CEBPA |
| Interaction | BCL9 interactions | 1.06e-05 | 86 | 247 | 8 | int:BCL9 | |
| Interaction | FMR1 interactions | NCOA3 BCL11A BCL9 LARP4 FBXO4 ATXN2 ZC3H7B THRAP3 PRRC2B AGAP2 PUM2 MAP7 TRIM67 TRIM28 KIAA1217 SMARCA4 PRKCG DOT1L PUM1 TNS1 | 1.09e-05 | 536 | 247 | 20 | int:FMR1 |
| Interaction | TLE6 interactions | 1.15e-05 | 25 | 247 | 5 | int:TLE6 | |
| Interaction | SNRNP40 interactions | BCL9L MAGEA6 KDM3A ZNF384 BCL9 ARID1A SCAF1 ARID1B POM121 SUPT5H CIZ1 TAF4 HSPG2 EP400 CPSF6 ZBTB4 POM121C PABIR2 TRIM67 SMARCA4 ZFHX3 DOT1L | 1.32e-05 | 637 | 247 | 22 | int:SNRNP40 |
| Interaction | ATXN1L interactions | 1.66e-05 | 150 | 247 | 10 | int:ATXN1L | |
| Interaction | SOX10 interactions | 1.74e-05 | 92 | 247 | 8 | int:SOX10 | |
| Interaction | TRAF2 interactions | CDCA3 RIPK1 KLF3 SPATA2 MYO15B POM121 SCNM1 FBXO28 MAP4K2 RAD23A EP400 SOX30 FBF1 CRYBA2 TRIM33 GORASP2 EAF1 TRIM67 KIAA1217 TNFRSF1B EP300 | 1.85e-05 | 603 | 247 | 21 | int:TRAF2 |
| Interaction | EWSR1 interactions | BCL9L NCOA3 NCOA6 ABL1 NACA BCORL1 MAML1 BCL9 SSBP3 ARID1A CIC TAF4 BAG6 THRAP3 RAD23A CPSF6 MRPS18B PCLO SALL4 CREBBP TRIM33 GORASP2 TRIM67 H1-3 SMARCA4 EP300 ATPAF2 | 1.94e-05 | 906 | 247 | 27 | int:EWSR1 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.25e-08 | 25 | 158 | 6 | 775 | |
| GeneFamily | PDZ domain containing | 7.65e-06 | 152 | 158 | 9 | 1220 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.07e-04 | 17 | 158 | 3 | 486 | |
| GeneFamily | CD molecules|Mucins | 7.76e-04 | 21 | 158 | 3 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 1.55e-03 | 7 | 158 | 2 | 570 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 SYN3 KIF1A BCL11A DCC SSBP3 ACSL4 NUAK1 CACNA1G HERC1 PRRC2B ANK2 PCLO APBA1 SALL4 RUNX1T1 RFX7 SGK2 LHX1 PACS1 FRY TRIM67 SHANK2 TENM1 ZFHX2 ZFHX3 IGSF9B CTNND2 SPAG17 RIMS2 TOX2 | 7.08e-08 | 1106 | 248 | 31 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | BCL11A DCC SSBP3 NUAK1 CACNA1G HERC1 ANK2 RUNX1T1 LHX1 FRY TRIM67 SHANK2 TENM1 ZFHX2 ZFHX3 DOT1L RIMS2 TOX2 PROX1 | 1.13e-07 | 465 | 248 | 19 | M39066 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 ZMYM2 LARP4 HIRA BBX ZFYVE9 NUAK1 ATXN2 AFF1 TAF4 CNOT2 MED13 SCHIP1 MAMLD1 PUM2 CREBBP TRIM33 TLE1 PUM1 | 1.17e-07 | 466 | 248 | 19 | M13522 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | PATZ1 NACA SH3GLB2 TMEM184A ATXN2 PI4KA PRR36 DUSP8 DENND1A CREB3L1 KMT2D SHANK2 TLE3 LRP3 CTNND2 GGA1 INPP5J | 1.81e-07 | 385 | 248 | 17 | M2840 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 KDM3A ZMYM2 LARP4 HIRA ACSL4 GJA1 BBX ZFYVE9 NUAK1 ATXN2 AFF1 TAF4 CNOT2 MED13 SCHIP1 MAMLD1 PUM2 CREBBP TRIM33 TLE1 NUP133 AKAP13 ZFHX3 PUM1 VPS13B | 1.90e-07 | 856 | 248 | 26 | M4500 |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | NCOA6 RAPGEF6 PCNX3 ZMYM2 HIRA KMT2C BBX PRRC2B ZBTB4 PACS1 KMT2D GAB3 | 5.02e-07 | 200 | 248 | 12 | M9439 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 NCOA3 SYNRG RAPGEF6 SH3BP1 ARID1A ACSL4 KMT2C BBX IL17RA HERC1 THRAP3 CNOT2 MED13 PRRC2B MICAL1 EP400 ZBTB4 AKNA PUM2 RFX7 CREBBP TRIM33 PACS1 MAP7D1 KMT2D RBM12 GAB3 AKAP13 EIF3F ASB2 SSBP4 TNFRSF1B EP300 VPS13B | 6.80e-07 | 1492 | 248 | 35 | M40023 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | PPRC1 SH3BP1 SRCAP CIC HIRA SCAF1 FOXO4 ZC3H7B TEPSIN APBA1 APBA3 KMT2D SMARCA4 DOT1L GGA1 | 9.11e-07 | 338 | 248 | 15 | M17094 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 ABL1 PPRC1 MAML1 BBX SATB1 AFF1 CNOT2 NPAS2 PUM2 CREBBP TP63 PUM1 VPS13B | 1.17e-06 | 300 | 248 | 14 | M8702 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 TMEM94 ARID1A KMT2C HERC1 MED13 RFX7 CREBBP TRIM33 TOX2 EP300 | 1.26e-06 | 180 | 248 | 11 | M8239 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | ZNF384 ABL1 PATZ1 NACA ZMYM2 BCL11A BCL9 TLX1 AFF1 THRAP3 RUNX1T1 CREBBP TRIM33 EP300 | 2.78e-06 | 323 | 248 | 14 | M9150 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | BCL9L NCOA3 NACA KLF3 SSBP3 ARID1A GGT5 ACSL4 CAVIN2 EP400 CD248 ECE1 MAP7D1 TLE3 AKAP13 ZFHX3 EIF3F SSBP4 TNS1 TCF7L1 | 9.37e-06 | 685 | 248 | 20 | MM3782 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | IRF2BP2 NCOA6 PCNX3 KLF3 BCL9 KMT2C THRAP3 RAD23A RFX7 CREBBP CUTA MAP7D1 ZFHX3 PUM1 PHLDB2 PDZD2 | 1.09e-05 | 467 | 248 | 16 | M1347 |
| Coexpression | BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS | 1.64e-05 | 85 | 248 | 7 | M40021 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | IRF2BP2 NCOA6 PCNX3 KLF3 BCL9 KMT2C THRAP3 RAD23A RFX7 CREBBP CUTA MAP7D1 ZFHX3 PUM1 PHLDB2 PDZD2 | 1.69e-05 | 484 | 248 | 16 | MM999 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.97e-05 | 157 | 248 | 9 | M7733 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | RAPGEF6 ARID1A RIPOR1 FOXO4 CEP97 KMT2D AKAP13 ZFHX3 EIF3F REPS2 | 2.24e-05 | 200 | 248 | 10 | M8050 |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 2.24e-05 | 200 | 248 | 10 | M6583 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | EVX1 DCC TLX1 KCNA5 ACAN CACNA1G ROBO3 PRKAG2 ARHGAP20 HOXB13 AGAP2 NPAS2 COL27A1 DUSP8 APBA1 CRYBA2 TRIM67 TRIM28 RASGEF1C GAB3 ZFHX3 SSBP4 TNFRSF1B CTNND2 REPS2 PDZD2 | 2.30e-05 | 1115 | 248 | 26 | M10371 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | KDM3A KLF3 WWC2 NUAK1 SYDE2 NPAS2 GULP1 SCHIP1 SALL4 PACS1 TLE1 TP63 KIAA1217 CTNND2 TCF7L1 PHLDB2 | 2.77e-05 | 504 | 248 | 16 | M2157 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | KIF1A LRRC37A3 SPATA31A7 SYNPO2L RBBP8NL KMT2C OPTC WWC2 MUC17 CNOT2 CAVIN2 CRYBG2 SPATA31A3 ANK2 SPATA31C2 AKNA RUNX1T1 DENND1A RASGEF1C TENM1 HMGXB3 GGA1 | 3.23e-05 | 873 | 248 | 22 | M16009 |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 6.02e-05 | 181 | 248 | 9 | M6849 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IRF2BP2 KLF3 ACSL4 KMT2C WWC2 BBX NID1 RIPOR1 MED13 CAVIN2 GULP1 SCHIP1 ZBTB4 ZDHHC14 PUM2 CREBBP FRY EAF1 DAAM2 MBD5 EP300 | 6.94e-05 | 854 | 248 | 21 | M1533 |
| Coexpression | BENPORATH_NANOG_TARGETS | BCL9L KDM3A RIPK1 PCNX3 BCL9 SSBP3 ACSL4 GJA1 SCAF1 ARID1B SCNM1 BAG6 NPAS2 RAD23A RUNX1T1 GORASP2 TLE3 KIAA1217 LRP3 TMEM108 EIF3F GGA1 TCF7L1 | 7.14e-05 | 988 | 248 | 23 | M6616 |
| Coexpression | BENPORATH_SOX2_TARGETS | KDM3A RIPK1 PCNX3 BCL9 SSBP3 GJA1 SCAF1 ARID1B SCNM1 NIT1 RAD23A MRPS18B TLE1 TLE3 TMEM108 EIF3F PUM1 GGA1 TCF7L1 | 7.96e-05 | 734 | 248 | 19 | M3835 |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 1.02e-04 | 194 | 248 | 9 | M3321 | |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 1.02e-04 | 194 | 248 | 9 | M5767 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | ARHGEF17 GGT5 ACSL4 GJA1 WWC2 NUAK1 SYDE2 NID1 RIPOR1 CAVIN2 GULP1 COL27A1 FRY CSPG4 TNS1 | 1.04e-04 | 505 | 248 | 15 | M39167 |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | KDM3A PATZ1 ZMYM2 ZNF395 HIRA HERC1 PRRC2B MAP7D1 TLE3 REPS2 | 1.19e-04 | 244 | 248 | 10 | M9945 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IRF2BP2 KLF3 ACSL4 KMT2C WWC2 BBX NID1 RIPOR1 MED13 CAVIN2 GULP1 SCHIP1 ZBTB4 ZDHHC14 PUM2 CREBBP FRY EAF1 DAAM2 MBD5 EP300 | 1.20e-04 | 888 | 248 | 21 | MM1018 |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 1.20e-04 | 198 | 248 | 9 | M3200 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 1.20e-04 | 198 | 248 | 9 | M7228 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_DN | 1.20e-04 | 198 | 248 | 9 | M6736 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | 1.20e-04 | 198 | 248 | 9 | M9245 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | LRRC37A3 SSBP3 ARID1A RXRB FBXO28 HERC1 ZDHHC14 TRIM33 TLE1 YLPM1 AKAP13 | 1.23e-04 | 294 | 248 | 11 | M41112 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.24e-04 | 199 | 248 | 9 | M9443 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.24e-04 | 199 | 248 | 9 | M9501 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | SYDE2 C4BPA MRPS18B TRIM33 TRIM28 NUP133 GAB3 HMGXB3 TNFRSF1B | 1.24e-04 | 199 | 248 | 9 | M4673 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP | 1.24e-04 | 199 | 248 | 9 | M3627 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 1.24e-04 | 199 | 248 | 9 | M9031 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 1.24e-04 | 199 | 248 | 9 | M9269 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 1.29e-04 | 200 | 248 | 9 | M9490 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 1.29e-04 | 200 | 248 | 9 | M7500 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 1.31e-04 | 11 | 248 | 3 | M1358 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 1.31e-04 | 11 | 248 | 3 | MM569 | |
| Coexpression | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN | 2.23e-04 | 13 | 248 | 3 | M17068 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | KIF1A BCORL1 HIRA NUAK1 MAP4K2 ANK2 PCLO MAMLD1 ZDHHC14 RUNX1T1 ZFHX2 RIMS2 PROX1 | 2.46e-04 | 429 | 248 | 13 | M45694 |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 2.74e-04 | 94 | 248 | 6 | M18108 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | BCL9L RIPK1 ZBTB22 CTTNBP2NL SCNM1 ZFYVE9 NUAK1 CACNA1G SAP130 SCHIP1 PACS1 RBM12 TRIM67 MAP1S ZFHX2 AKAP13 PRKCG SSBP4 CTNND2 GGA1 PHLDB2 | 3.15e-04 | 954 | 248 | 21 | MM3689 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 PATZ1 BCORL1 BCL11A SRCAP SSBP3 KMT2C SATB1 ATXN2 NID1 HERC1 ARHGAP20 THRAP3 GULP1 RAD23A MGAM RUNX1T1 ECE1 CREBBP LHX1 ADGRG2 TLE3 KIAA1217 SMARCA4 ZFHX3 PUM1 TNS1 | 6.09e-07 | 801 | 244 | 27 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 PATZ1 BCORL1 BCL11A SRCAP SSBP3 KMT2C KCNA5 ATXN2 NID1 HERC1 ARHGAP20 THRAP3 CAVIN2 MGAM ZBTB4 RUNX1T1 ECE1 CREBBP CREB3L1 LHX1 ADGRG2 TLE3 KIAA1217 PUM1 TNS1 | 1.55e-06 | 790 | 244 | 26 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NCOA3 PATZ1 BCORL1 SRCAP SSBP3 ATXN2 NID1 HERC1 ARHGAP20 MGAM RUNX1T1 CREBBP LHX1 ADGRG2 KIAA1217 PUM1 TNS1 | 6.41e-06 | 413 | 244 | 17 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NCOA3 PATZ1 SRCAP SSBP3 ARID1A LARP4 WWC2 BBX TMEM184A ATXN2 HERC1 ARHGAP20 THRAP3 RAD23A MGAM SALL4 RUNX1T1 ECE1 CREBBP LHX1 KIAA1217 SMARCA4 PUM1 TOX2 TNS1 | 7.02e-06 | 806 | 244 | 25 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NCOA3 PATZ1 BCORL1 SRCAP SSBP3 KMT2C ATXN2 DTX4 NID1 HERC1 ARHGAP20 THRAP3 CAVIN2 RAD23A CNDP1 MGAM COL27A1 RUNX1T1 CREBBP LHX1 ADGRG2 KIAA1217 PUM1 TNS1 | 1.83e-05 | 799 | 244 | 24 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NCOA3 PATZ1 BCORL1 SRCAP SSBP3 ATXN2 NID1 HERC1 ARHGAP20 MGAM RUNX1T1 CREBBP ADGRG2 KIAA1217 PUM1 TNS1 | 2.06e-05 | 406 | 244 | 16 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | ZNF395 SSBP3 ARID1A GJA1 SCAF1 BBX TMEM184A ATXN2 NID1 BAG6 THRAP3 RAD23A PUM2 SALL4 RUNX1T1 ECE1 CREB3L1 LHX1 GORASP2 NUP133 SMARCA4 SSBP4 PUM1 TNS1 | 2.72e-05 | 819 | 244 | 24 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA6 SYN3 KIF1A MED14 ZMYM2 KLF3 FAM110A BCL11A DCC LARP4 ACSL4 DTX4 ROBO3 MAML3 CEP97 PRR36 PCLO MAMLD1 SALL4 MAP7 LHX1 SMARCA4 ZFHX2 CTNND2 RIMS2 TOX2 PROX1 | 2.92e-05 | 989 | 244 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | KIF1A MED14 SRCAP ARID1A ZFYVE9 FBXO28 DTX4 RPRD2 PRKAG2 SAP130 MAML3 CNOT2 PCLO MAMLD1 TRIM33 YLPM1 CTNND2 RIMS2 EP300 | 6.30e-05 | 595 | 244 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | KIF1A FAM110A BCL11A TMEM184A CEP97 CRYBG2 PRR36 PCLO MAP7 RAB11FIP1 TP63 SMARCA4 ZFHX2 ZFHX3 CTNND2 RIMS2 TOX2 | 6.40e-05 | 495 | 244 | 17 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.47e-04 | 99 | 244 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | KIF1A FAM110A BCL11A DCC DTX4 ROBO3 PRR36 PCLO MAMLD1 SALL4 H1-3 ZFHX2 CTNND2 RIMS2 TOX2 PROX1 | 1.55e-04 | 482 | 244 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 PATZ1 BCL11A SRCAP SSBP3 ARID1A LARP4 SATB1 HERC1 ARHGAP20 CEP97 GULP1 MGAM SALL4 RUNX1T1 ECE1 CREBBP LHX1 TLE3 SMARCA4 ZFHX3 PUM1 | 1.93e-04 | 815 | 244 | 22 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | SSBP3 ARID1A BBX TMEM184A THRAP3 RAD23A SALL4 ECE1 SMARCA4 PUM1 TNS1 | 2.30e-04 | 261 | 244 | 11 | gudmap_developingGonad_e12.5_epididymis_k1_1000 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | LRRC37A3 KMT2C ARID1B AFF1 HERC1 MAML3 RFX7 DENND1A PACS1 SHANK2 MBD5 VPS13B | 1.53e-09 | 199 | 250 | 12 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 KCNA5 GPR20 CD248 CSPG4 ZFHX3 ASB2 DOT1L GGA1 TNS1 PHLDB2 | 8.59e-09 | 185 | 250 | 11 | 38486b69c48dc5e1c4e1488208fa8954a973eccb |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 KCNA5 GPR20 CD248 CSPG4 ZFHX3 ASB2 DOT1L GGA1 TNS1 PHLDB2 | 8.59e-09 | 185 | 250 | 11 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PATZ1 KMT2C SATB1 RIPOR1 IL17RA CNOT2 PUM2 RBM12 TRIM28 H1-3 SMARCA4 | 1.41e-08 | 194 | 250 | 11 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PATZ1 KMT2C SATB1 RIPOR1 IL17RA CNOT2 PUM2 RBM12 TRIM28 H1-3 SMARCA4 | 1.41e-08 | 194 | 250 | 11 | cda1b197efb199330ea7ab25a7cee22cae22589d |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.65e-08 | 166 | 250 | 10 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.43e-08 | 179 | 250 | 10 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.43e-08 | 179 | 250 | 10 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 ARID1A ARID1B ATXN2 SPATS2 MAML3 MED13 COL27A1 CTNND2 PUM1 | 1.06e-07 | 186 | 250 | 10 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | IRF2BP2 SH3BP1 KMT2C IL17RA TET3 PCLO MUC16 DAAM2 ZFHX3 SPAG17 | 1.06e-07 | 186 | 250 | 10 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 ARID1A ARID1B ATXN2 SPATS2 MAML3 MED13 COL27A1 CTNND2 PUM1 | 1.06e-07 | 186 | 250 | 10 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 GGT5 KCNA5 NID1 GPR20 CD248 CSPG4 ZFHX3 ASB2 PHLDB2 | 1.36e-07 | 191 | 250 | 10 | cb75e6c36dbe2e091e407d691c063ec7c4fd5f90 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 GGT5 KCNA5 NID1 GPR20 CD248 CSPG4 ZFHX3 ASB2 PHLDB2 | 1.36e-07 | 191 | 250 | 10 | b2cffea7860dd590b505ee0ebd51aa1978cb5e64 |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.36e-07 | 191 | 250 | 10 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 GGT5 KCNA5 NID1 GPR20 CD248 CSPG4 ZFHX3 ASB2 PHLDB2 | 1.43e-07 | 192 | 250 | 10 | e5117cdb8af220f60bd1410262078c0306667b4a |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | RALGAPA1 SYNRG BCL9 ARID1A AFF1 CEP97 MED13 TRIM33 PUM1 VPS13B | 1.50e-07 | 193 | 250 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PATZ1 KMT2C SATB1 RIPOR1 IL17RA CNOT2 PUM2 TRIM28 H1-3 SMARCA4 | 1.58e-07 | 194 | 250 | 10 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PATZ1 SATB1 AFF1 RIPOR1 IL17RA CEP97 CNOT2 TRIM28 H1-3 SMARCA4 | 1.65e-07 | 195 | 250 | 10 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | SYN3 KIF1A MAML3 ANK2 PCLO RUNX1T1 TMEM108 RIMS2 INPP5J PROX1 | 1.82e-07 | 197 | 250 | 10 | ff4df77117165b6b25315e29b0722cc136eba607 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-07 | 174 | 250 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | WWC2 ZFYVE9 IQCJ-SCHIP1 RAB11FIP1 SHANK2 CTNND2 TNS1 PHLDB2 PDZD2 | 6.44e-07 | 174 | 250 | 9 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | WWC2 SYDE2 IQCJ-SCHIP1 RAB11FIP1 SHANK2 CTNND2 REPS2 PHLDB2 PDZD2 | 8.16e-07 | 179 | 250 | 9 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.81e-07 | 183 | 250 | 9 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 250 | 9 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 184 | 250 | 9 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 184 | 250 | 9 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 250 | 9 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 250 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 189 | 250 | 9 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 189 | 250 | 9 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 189 | 250 | 9 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 189 | 250 | 9 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | WWC2 C4BPA IQCJ-SCHIP1 RAB11FIP1 SHANK2 CTNND2 TNS1 PHLDB2 PDZD2 | 1.34e-06 | 190 | 250 | 9 | 30b50d183d7649146eb1e79b47ba897355f1998a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 192 | 250 | 9 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 192 | 250 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 192 | 250 | 9 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-06 | 193 | 250 | 9 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-06 | 193 | 250 | 9 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 193 | 250 | 9 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-06 | 193 | 250 | 9 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-06 | 194 | 250 | 9 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-06 | 194 | 250 | 9 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-06 | 197 | 250 | 9 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-06 | 199 | 250 | 9 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SRCAP KMT2C PRKAG2 MAML3 MAMLD1 DENND1A AKAP13 TNFRSF1B TNS1 | 1.96e-06 | 199 | 250 | 9 | 379bbd9cecf466b902411c54d74bd9885285b1ba |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 168 | 250 | 8 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 170 | 250 | 8 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 170 | 250 | 8 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 170 | 250 | 8 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.51e-06 | 174 | 250 | 8 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.07e-06 | 176 | 250 | 8 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-06 | 176 | 250 | 8 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 250 | 8 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.07e-06 | 176 | 250 | 8 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 250 | 8 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.37e-06 | 177 | 250 | 8 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-06 | 178 | 250 | 8 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 8.01e-06 | 179 | 250 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.01e-06 | 179 | 250 | 8 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-06 | 179 | 250 | 8 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.68e-06 | 181 | 250 | 8 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-06 | 181 | 250 | 8 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-06 | 182 | 250 | 8 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-06 | 182 | 250 | 8 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 183 | 250 | 8 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 9.41e-06 | 183 | 250 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 183 | 250 | 8 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.79e-06 | 184 | 250 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.79e-06 | 184 | 250 | 8 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.79e-06 | 184 | 250 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 185 | 250 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.02e-05 | 185 | 250 | 8 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 185 | 250 | 8 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 185 | 250 | 8 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | WWC2 C4BPA IQCJ-SCHIP1 CAVIN2 RAB11FIP1 SHANK2 CTNND2 PHLDB2 | 1.02e-05 | 185 | 250 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-05 | 185 | 250 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 185 | 250 | 8 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.06e-05 | 186 | 250 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 186 | 250 | 8 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 187 | 250 | 8 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | WWC2 IQCJ-SCHIP1 HSPG2 RAB11FIP1 SHANK2 KIAA1217 CTNND2 PHLDB2 | 1.10e-05 | 187 | 250 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 187 | 250 | 8 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 187 | 250 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 188 | 250 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 189 | 250 | 8 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.19e-05 | 189 | 250 | 8 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 189 | 250 | 8 | ff637ae0afdb1fdc67451be7e1e4fe575fbcfff4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 189 | 250 | 8 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 189 | 250 | 8 | e127e3be626bc513e151d41812f0b7adb89d5da6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 190 | 250 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 190 | 250 | 8 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 190 | 250 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 190 | 250 | 8 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 191 | 250 | 8 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 191 | 250 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 192 | 250 | 8 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 192 | 250 | 8 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.33e-05 | 192 | 250 | 8 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.33e-05 | 192 | 250 | 8 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| Drug | AC1L2E0P | NCOA3 NCOA6 RIPK1 PPRC1 MED14 RXRB ZFYVE9 AFF1 NID1 TAF4 NPAS2 RUNX1T1 CREBBP TRIM33 TRIM28 SMARCA4 EP300 PROX1 | 6.16e-09 | 307 | 243 | 18 | CID000019390 |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A | BCL9 C2CD2L ACAN HOXB13 NPAS2 HSPG2 ZDHHC14 SGK2 CRYBA2 TLE3 YLPM1 LRP3 AKAP13 | 2.42e-07 | 199 | 243 | 13 | 1888_UP |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | SYNRG PPRC1 BCL11A SRCAP SUPT5H RIPOR1 ROBO3 ZC3H7B PRRC2B MICAL1 PRR36 LRP3 | 1.40e-06 | 196 | 243 | 12 | 1819_DN |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | BCL9 ARHGEF17 CIC HIRA RIPOR1 MAP4K2 PRRC2B MICAL1 CD248 PRR36 ECE1 INPP5J | 1.48e-06 | 197 | 243 | 12 | 2766_UP |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | KIF1A SH3BP1 MED14 ZFYVE9 CACNA1G CREBBP PACS1 SHANK2 TP63 YLPM1 REPS2 INPP5J | 1.56e-06 | 198 | 243 | 12 | 2424_UP |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | SRCAP ACAN RIPOR1 IL17RA MICAL1 PRR36 ZDHHC14 CREBBP PACS1 YLPM1 RIMS2 TNS1 | 1.65e-06 | 199 | 243 | 12 | 3860_DN |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; MCF7; HT_HG-U133A | SYN3 EVX1 CDHR5 SRCAP ARID1A ACSL4 MAP4K2 AGAP2 ANK2 SGK2 SHANK2 MUC6 | 1.74e-06 | 200 | 243 | 12 | 3176_UP |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | SYNRG ZNF189 ARID1A FBXO28 CNOT2 PUM2 CREBBP TRIM33 TLE1 PUM1 EP300 | 3.95e-06 | 180 | 243 | 11 | 4541_DN |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | PATZ1 MAML1 BCL9 SRCAP ARID1A CIC ATXN2 RIPOR1 ZC3H7B TLE1 INPP5J | 8.49e-06 | 195 | 243 | 11 | 1665_DN |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | BCORL1 BCL11A ACAN CIZ1 NID1 NPAS2 RUNX1T1 ECE1 TP63 RIMS2 TCF7L1 | 8.91e-06 | 196 | 243 | 11 | 4409_UP |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | MAML1 KLF3 ACSL4 ZC3H7B CRYBG2 DUSP8 APBA1 POM121L2 RELB H1-3 INPP5J | 8.91e-06 | 196 | 243 | 11 | 6821_UP |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A | SYN3 MAML1 BCL11A ZFYVE9 ACAN C4BPA ZC3H7B POM121L2 RELB RUNX1T1 PROX1 | 8.91e-06 | 196 | 243 | 11 | 4508_UP |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | BCL11A ARHGEF17 C2CD2L ACSL4 ZFYVE9 RIPOR1 PACS1 TLE3 H1-3 ZFHX3 TCF7L1 | 9.81e-06 | 198 | 243 | 11 | 5793_DN |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A | SYNRG RIPK1 C2CD2L WWC2 ACAN PI4KA AFF1 ZC3H7B ANK2 GORASP2 TLE1 | 9.81e-06 | 198 | 243 | 11 | 1574_UP |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A | SH3GLB2 UNC45A HIRA CEP97 PRRC2B TRIM33 MAP7D1 SHANK2 YLPM1 TNS1 ATPAF2 | 1.03e-05 | 199 | 243 | 11 | 6355_DN |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; PC3; HG-U133A | NCOA3 ZFYVE9 ATXN2 ACAN CIZ1 HOXB13 HSPG2 CPSF6 TLE3 YLPM1 LRP3 | 1.03e-05 | 199 | 243 | 11 | 1931_UP |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | BCORL1 KCNA5 NID1 NPAS2 HSPG2 APBA1 RELB TP63 TNS1 INPP5J PDZD2 | 1.03e-05 | 199 | 243 | 11 | 3934_UP |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | SYN3 LILRB2 ZFYVE9 ZC3H7B MPZ ANK2 SOX30 RUNX1T1 SHANK2 TNS1 MUC6 | 1.08e-05 | 200 | 243 | 11 | 3760_UP |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NCOA6 PPRC1 PATZ1 ARID1A NUAK1 RPRD2 PUM2 CREBBP ZFHX3 EP300 | 1.68e-05 | 172 | 243 | 10 | 1072_DN |
| Drug | polyproline | ABL1 RIPK1 PPRC1 SH3BP1 ZNF395 C4BPA TAF4 BAG6 MICAL1 SHANK2 TENM1 GAB3 CTNND2 | 1.87e-05 | 295 | 243 | 13 | CID000439587 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | KDM3A ARID1A FBXO28 TAF4 CNOT2 MED13 PUM2 CREBBP TRIM33 PUM1 | 2.74e-05 | 182 | 243 | 10 | 3887_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 184 | 243 | 10 | 2321_DN | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | SRCAP ACAN C4BPA ZC3H7B ZDHHC14 RELB CREBBP SGK2 PACS1 AKAP13 | 3.96e-05 | 190 | 243 | 10 | 3888_UP |
| Drug | C75; Down 200; 10uM; PC3; HT_HG-U133A | 4.14e-05 | 191 | 243 | 10 | 6399_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.32e-05 | 192 | 243 | 10 | 1076_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | PPRC1 ARID1A WWC2 SUPT5H RIPOR1 PRR36 DUSP8 APBA3 TLE3 REPS2 | 4.52e-05 | 193 | 243 | 10 | 1644_DN |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 4.52e-05 | 193 | 243 | 10 | 5600_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.52e-05 | 193 | 243 | 10 | 4154_DN | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | LILRB2 SRCAP HIRA ZFYVE9 DTX4 MAP4K2 HSPG2 ZDHHC14 LRP3 TNS1 | 4.52e-05 | 193 | 243 | 10 | 2129_DN |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.72e-05 | 194 | 243 | 10 | 3828_DN | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 4.72e-05 | 194 | 243 | 10 | 828_UP | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | SYNPO2L CACNA1G RELB ECE1 KMT2D TLE1 H1-3 RIMS2 INPP5J ATPAF2 | 4.93e-05 | 195 | 243 | 10 | 871_UP |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.93e-05 | 195 | 243 | 10 | 3850_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A | NCOA3 TMEM94 MAML1 BCL11A UNC45A HIRA MED13 PRRC2B TLE1 AKAP13 | 5.15e-05 | 196 | 243 | 10 | 2019_DN |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | 5.15e-05 | 196 | 243 | 10 | 4560_DN | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | RIPK1 WWC2 SUPT5H PRRC2B EP400 DUSP8 CREB3L1 CRYBA2 TNS1 PDZD2 | 5.15e-05 | 196 | 243 | 10 | 6295_DN |
| Drug | retinoic acid; Down 200; 1uM; HL60; HG-U133A | PPRC1 BCL11A UNC45A ACAN RIPOR1 PRRC2B RUNX1T1 SGK2 TRIM33 TP63 | 5.15e-05 | 196 | 243 | 10 | 390_DN |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | KLF3 BCL9 KCNA5 CACNA1G CRYBG2 PCLO CREBBP CREB3L1 H1-3 PROX1 | 5.15e-05 | 196 | 243 | 10 | 2560_UP |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A | SPATA2 HIRA WWC2 ZC3H7B ARMH3 ZDHHC14 MAP7 YLPM1 AKAP13 EP300 | 5.15e-05 | 196 | 243 | 10 | 7123_DN |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A | 5.37e-05 | 197 | 243 | 10 | 7260_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.37e-05 | 197 | 243 | 10 | 3978_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | PPRC1 BCORL1 ZNF189 ZMYM2 ARID1A ATXN2 AFF1 RPRD2 PRRC2B MAP1S | 5.37e-05 | 197 | 243 | 10 | 2034_DN |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | SH3GLB2 UNC45A HIRA NID1 ZC3H7B ARMH3 ECE1 MAP7D1 ADGRG2 SMARCA4 | 5.37e-05 | 197 | 243 | 10 | 6360_DN |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; PC3; HT_HG-U133A | RALGAPA1 ZMYM2 BCL11A UNC45A ZFYVE9 MICAL1 RAB11FIP1 RUNX1T1 GGA1 VPS13B | 5.60e-05 | 198 | 243 | 10 | 7278_UP |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | TMEM94 LILRB2 BCORL1 ACAN NID1 RIPOR1 IL17RA SHANK2 RIMS2 GGA1 | 5.60e-05 | 198 | 243 | 10 | 3237_UP |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; HL60; HT_HG-U133A | 5.60e-05 | 198 | 243 | 10 | 2495_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A | TMEM94 MED14 BCL11A ARMH3 PRRC2B EP400 APBA3 DENND1A SMARCA4 AKAP13 | 5.60e-05 | 198 | 243 | 10 | 1595_DN |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | ZMYM2 KCNA5 SUPT5H AFF1 ZC3H7B PACS1 H1-3 HMGXB3 CTNND2 TNS1 | 5.60e-05 | 198 | 243 | 10 | 4669_DN |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.60e-05 | 198 | 243 | 10 | 6287_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; HL60; HG-U133A | TMEM94 NACA UNC45A SPATA2 ACSL4 CIZ1 RPRD2 ARMH3 APBA3 HMGXB3 | 5.60e-05 | 198 | 243 | 10 | 1731_DN |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.60e-05 | 198 | 243 | 10 | 1482_DN | |
| Drug | iminodiacetic acid | 5.68e-05 | 63 | 243 | 6 | CID000008897 | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; HL60; HT_HG-U133A | C2CD2L RIPOR1 FOXO4 ZC3H7B CRYBG2 DUSP8 MAP7 TLE3 YLPM1 ZFHX3 | 5.85e-05 | 199 | 243 | 10 | 2363_UP |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | KIF1A BCORL1 MED14 SPATA2 PRRC2B POM121L2 RUNX1T1 CREB3L1 ADGRG2 H1-3 | 5.85e-05 | 199 | 243 | 10 | 7125_UP |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | ARID1A C4BPA MAP4K2 APBA3 CREBBP LHX1 LRP3 RIMS2 TNS1 ATPAF2 | 5.85e-05 | 199 | 243 | 10 | 3845_DN |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | NCOA3 SH3GLB2 ARID1A C2CD2L NID1 SHANK2 ZFHX3 GGA1 TNS1 ATPAF2 | 5.85e-05 | 199 | 243 | 10 | 6361_DN |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | PATZ1 UNC45A SRCAP RIPOR1 ZC3H7B HSPG2 DUSP8 MAP7 CREB3L1 GGA1 | 5.85e-05 | 199 | 243 | 10 | 7287_UP |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | KIF1A ARID1A ROBO3 ZC3H7B CEP97 PRR36 ECE1 TRIM33 H1-3 AKAP13 | 6.10e-05 | 200 | 243 | 10 | 4824_DN |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A | 6.10e-05 | 200 | 243 | 10 | 2558_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 168 | 243 | 9 | 6087_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.21e-05 | 170 | 243 | 9 | 1050_DN | |
| Drug | AC1O1I4V | 1.13e-04 | 2 | 243 | 2 | CID000516923 | |
| Drug | semduramicin | 1.13e-04 | 2 | 243 | 2 | CID000071327 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.25e-04 | 177 | 243 | 9 | 4652_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.31e-04 | 178 | 243 | 9 | 1112_DN | |
| Drug | glutamin | NCOA3 ZNF384 MAML1 EVX1 ARID1A CIC GGT5 CIZ1 TAF4 RAD23A MAMLD1 RUNX1T1 CREBBP PRKCG EP300 | 1.40e-04 | 461 | 243 | 15 | CID000000738 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.42e-04 | 180 | 243 | 9 | 6886_DN | |
| Drug | amoxicillin-clavulanate | 1.86e-04 | 11 | 243 | 3 | CID006435924 | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A | 1.89e-04 | 187 | 243 | 9 | 6764_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; HL60; HG-U133A | RIPK1 ZMYM2 UNC45A HIRA ZC3H7B MGAM RAB11FIP1 AKAP13 TNFRSF1B | 1.97e-04 | 188 | 243 | 9 | 2000_UP |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 2.05e-04 | 189 | 243 | 9 | 989_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 2.05e-04 | 189 | 243 | 9 | 410_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.22e-04 | 191 | 243 | 9 | 4168_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.31e-04 | 192 | 243 | 9 | 2078_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; HL60; HG-U133A | 2.31e-04 | 192 | 243 | 9 | 1413_DN | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.31e-04 | 192 | 243 | 9 | 6213_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 2.40e-04 | 193 | 243 | 9 | 431_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 6427_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 3412_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 7008_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 4306_UP | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 2.40e-04 | 193 | 243 | 9 | 1228_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 1670_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 4424_DN | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 7399_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 3861_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A | 2.49e-04 | 194 | 243 | 9 | 1712_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 4126_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 2.49e-04 | 194 | 243 | 9 | 1715_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A | 2.49e-04 | 194 | 243 | 9 | 1759_UP | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 7442_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 194 | 243 | 9 | 6833_UP | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.59e-04 | 195 | 243 | 9 | 6701_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.59e-04 | 195 | 243 | 9 | 6338_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A | 2.59e-04 | 195 | 243 | 9 | 2017_DN | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A | 2.59e-04 | 195 | 243 | 9 | 1605_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 2.59e-04 | 195 | 243 | 9 | 1293_DN | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; HL60; HT_HG-U133A | 2.59e-04 | 195 | 243 | 9 | 3034_UP | |
| Drug | 5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA | 2.59e-04 | 195 | 243 | 9 | 908_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 243 | 9 | 7451_DN | |
| Disease | Malignant neoplasm of breast | NCOA3 KDM3A NCOA6 ABL1 BCORL1 LRRC37A2 MED14 BCL11A ARID1A CIC RXRB GJA1 ARID1B LRRC37A KCNA5 AFF1 HOXB13 ZNF541 AGAP2 MICAL1 ANK2 KMT2D TLE3 TENM1 NUP133 REPS2 GGA1 TNS1 TCF7L1 EP300 VPS13B | 1.49e-09 | 1074 | 243 | 31 | C0006142 |
| Disease | Sezary Syndrome | 7.51e-08 | 27 | 243 | 6 | C0036920 | |
| Disease | Adenoid Cystic Carcinoma | 1.49e-07 | 100 | 243 | 9 | C0010606 | |
| Disease | Intellectual Disability | RALGAPA1 TMEM94 ZMYM2 BCL11A DCC CIC KMT2C CACNA1G TET3 MED13 CNDP1 PACS1 FRY SHANK2 PRKCG EIF3F PUM1 | 2.15e-07 | 447 | 243 | 17 | C3714756 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.45e-06 | 5 | 243 | 3 | C3281201 | |
| Disease | alcohol use disorder (implicated_via_orthology) | KDM3A ACSS2 ARID1A ARID1B CIZ1 MAP4K2 CREBBP SMARCA4 PRKCG EP300 | 5.46e-06 | 195 | 243 | 10 | DOID:1574 (implicated_via_orthology) |
| Disease | Paroxysmal atrial fibrillation | 6.27e-06 | 156 | 243 | 9 | C0235480 | |
| Disease | familial atrial fibrillation | 6.27e-06 | 156 | 243 | 9 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.27e-06 | 156 | 243 | 9 | C2585653 | |
| Disease | Atrial Fibrillation | 7.69e-06 | 160 | 243 | 9 | C0004238 | |
| Disease | obesity (implicated_via_orthology) | KDM3A PNPLA1 MED13 PUM2 GORASP2 ZFHX2 ZFHX3 PUM1 TCF7L1 PROX1 | 1.29e-05 | 215 | 243 | 10 | DOID:9970 (implicated_via_orthology) |
| Disease | Profound Mental Retardation | 2.10e-05 | 139 | 243 | 8 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.10e-05 | 139 | 243 | 8 | C0025363 | |
| Disease | Mental deficiency | 2.10e-05 | 139 | 243 | 8 | C0917816 | |
| Disease | neuroticism measurement, cognitive function measurement | BCL11A DCC ARID1A SCAF1 BBX NPAS2 CD248 PCLO ECE1 DENND1A KIAA1217 YLPM1 ZFHX3 IGSF9B CTNND2 PROX1 | 2.12e-05 | 566 | 243 | 16 | EFO_0007660, EFO_0008354 |
| Disease | longitudinal alcohol consumption measurement | 4.47e-05 | 9 | 243 | 3 | EFO_0007645 | |
| Disease | prostate cancer (is_marker_for) | 4.80e-05 | 156 | 243 | 8 | DOID:10283 (is_marker_for) | |
| Disease | sexual dimorphism measurement | RALGAPA1 NCOA6 RAPGEF6 SYN3 KIF1A ACSS2 ARID1A SPATA31C1 PNPLA1 ACAN HERC1 AGAP2 MGAM CD248 ZBTB4 SPATA31C2 POM121L2 RELB PACS1 SMARCA4 CD300LG ZFHX3 DOT1L | 4.85e-05 | 1106 | 243 | 23 | EFO_0021796 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 6.75e-05 | 2 | 243 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.75e-05 | 2 | 243 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.75e-05 | 2 | 243 | 2 | cv:C4551859 | |
| Disease | GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1 | 6.75e-05 | 2 | 243 | 2 | C4551964 | |
| Disease | Menke-Hennekam syndrome | 6.75e-05 | 2 | 243 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.75e-05 | 2 | 243 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.75e-05 | 2 | 243 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.75e-05 | 2 | 243 | 2 | C4551859 | |
| Disease | Gaze Palsy, Familial Horizontal, with Progressive Scoliosis | 6.75e-05 | 2 | 243 | 2 | C1846496 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.75e-05 | 2 | 243 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.75e-05 | 2 | 243 | 2 | C0035934 | |
| Disease | Small cell carcinoma of lung | 8.27e-05 | 54 | 243 | 5 | C0149925 | |
| Disease | coagulation factor XA measurement | 8.67e-05 | 11 | 243 | 3 | EFO_0020266 | |
| Disease | FEV/FEC ratio | SYN3 BCL11A DCC ARHGEF17 CTTNBP2NL GJA1 WWC2 ACAN RIPOR1 HERC1 ARHGAP20 HSPG2 MGAM GPR20 SOX30 RUNX1T1 TRIM33 CSPG4 YLPM1 RASGEF1C ZFHX3 TNS1 TCF7L1 PHLDB2 | 8.67e-05 | 1228 | 243 | 24 | EFO_0004713 |
| Disease | blood phosphate measurement | 1.03e-04 | 174 | 243 | 8 | EFO_0010972 | |
| Disease | cortical thickness | IRF2BP2 NFILZ DAB1 SSBP3 ARID1B KCNA5 NUAK1 ATXN2 PI4KA AFF1 IQCJ-SCHIP1 PRKAG2 HSPG2 CPSF6 RUNX1T1 ECE1 DENND1A YLPM1 RASGEF1C TMEM108 TNS1 PDZD2 | 1.47e-04 | 1113 | 243 | 22 | EFO_0004840 |
| Disease | Coffin-Siris syndrome | 1.48e-04 | 13 | 243 | 3 | C0265338 | |
| Disease | coagulation factor X measurement | 1.48e-04 | 13 | 243 | 3 | EFO_0020265 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.60e-04 | 139 | 243 | 7 | DOID:3908 (is_implicated_in) | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.71e-04 | 34 | 243 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.71e-04 | 34 | 243 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.71e-04 | 34 | 243 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.71e-04 | 34 | 243 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.71e-04 | 34 | 243 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.71e-04 | 34 | 243 | 4 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.92e-04 | 35 | 243 | 4 | C0752122 | |
| Disease | neurotic disorder | 1.94e-04 | 101 | 243 | 6 | EFO_0004257 | |
| Disease | Burkitt Lymphoma | 2.15e-04 | 36 | 243 | 4 | C0006413 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.15e-04 | 103 | 243 | 6 | EFO_0008595, EFO_0020944 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.77e-04 | 152 | 243 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 2.85e-04 | 16 | 243 | 3 | C0079772 | |
| Disease | body surface area | RALGAPA1 SYN3 KIF1A E2F7 ACSS2 SSBP3 SPATA31C1 WWC2 ACAN ZBTB4 SPATA31C2 MAP7D1 AKAP13 ZFHX3 DOT1L | 3.15e-04 | 643 | 243 | 15 | EFO_0022196 |
| Disease | Adenocarcinoma of lung (disorder) | 3.27e-04 | 206 | 243 | 8 | C0152013 | |
| Disease | mean platelet volume | PCNX3 NACA BCORL1 KLF3 SRCAP ACSL4 BBX ATXN2 PI4KA FBXO28 AFF1 NID1 RIPOR1 C4BPA CAVIN2 MICAL1 GPR20 ZDHHC14 FRY GORASP2 | 3.27e-04 | 1020 | 243 | 20 | EFO_0004584 |
| Disease | Carcinoma, Transitional Cell | 3.58e-04 | 41 | 243 | 4 | C0007138 | |
| Disease | Congenital Heart Defects | 4.70e-04 | 44 | 243 | 4 | C0018798 | |
| Disease | cytokine measurement | SSBP3 BBX SYDE2 IQCJ-SCHIP1 ANK2 CPSF6 DENND1A C4orf54 PACS1 TRIM67 TOX2 TCF7L1 | 4.81e-04 | 461 | 243 | 12 | EFO_0004873 |
| Disease | diastolic blood pressure, systolic blood pressure | MAML1 BCL9 RBBP8NL GJA1 ARID1B ATXN2 ACAN AFF1 MAP4K2 NPAS2 GULP1 ANK2 TRIM33 ZFHX3 TCF7L1 | 4.84e-04 | 670 | 243 | 15 | EFO_0006335, EFO_0006336 |
| Disease | Cleft palate, cleft lip | SPATA31C1 MPZ SPATA31C2 SALL4 CREBBP TLE1 TP63 VPS13B PHLDB2 | 5.45e-04 | 279 | 243 | 9 | EFO_0003959, HP_0000175 |
| Disease | Breast Carcinoma | NCOA3 ABL1 LRRC37A2 ARID1A RXRB GJA1 ARID1B LRRC37A HOXB13 KMT2D TLE3 REPS2 EP300 | 5.68e-04 | 538 | 243 | 13 | C0678222 |
| Disease | vital capacity | NCOA3 NCOA6 KIF1A DCC TMEM184A ACAN RTL9 AFF1 RIPOR1 RPRD2 HSPG2 MICAL1 PCLO ZBTB4 POM121L2 TPRX2 GAB3 ZFHX3 DOT1L SSBP4 TNS1 PDZD2 | 6.14e-04 | 1236 | 243 | 22 | EFO_0004312 |
| Disease | Alzheimer's disease biomarker measurement | 6.57e-04 | 48 | 243 | 4 | EFO_0006514 | |
| Disease | Sarcoma | 6.57e-04 | 21 | 243 | 3 | C1261473 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 6.64e-04 | 5 | 243 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Hypoplastic Left Heart Syndrome | 6.64e-04 | 5 | 243 | 2 | C0152101 | |
| Disease | Klatskin's tumor (is_implicated_in) | 6.64e-04 | 5 | 243 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Tourette syndrome | 7.68e-04 | 50 | 243 | 4 | EFO_0004895 | |
| Disease | feeling nervous measurement | 7.76e-04 | 87 | 243 | 5 | EFO_0009597 | |
| Disease | body weight | RALGAPA1 E2F7 DCC SSBP3 SPATA31C1 OPTC ACAN MAML3 MPZ MGAM SPATA31C2 POM121L2 RUNX1T1 ECE1 POM121C DENND1A SGK2 MAP7D1 KIAA1217 ZFHX3 DOT1L PDZD2 | 7.99e-04 | 1261 | 243 | 22 | EFO_0004338 |
| Disease | obsolete_red blood cell distribution width | IRF2BP2 ABL1 SYN3 PATZ1 LRRC37A2 KLF3 BCL11A MUC17 HERC1 PRKAG2 ZC3H7B EP400 ZDHHC14 RELB ECE1 TRIM33 KIAA1217 YLPM1 CD300LG AKAP13 SSBP4 TOX2 EP300 | 8.12e-04 | 1347 | 243 | 23 | EFO_0005192 |
| Disease | myeloid white cell count | ABL1 SH3BP1 KLF3 BCL9 CIC GGT5 GJA1 BBX ATXN2 SUPT5H IL17RA TLE3 ZFHX3 DOT1L SSBP4 SPAG17 GGA1 TCF7L1 | 8.21e-04 | 937 | 243 | 18 | EFO_0007988 |
| Disease | PR interval | PCNX3 SYNPO2L DAB1 SSBP3 AFF1 CACNA1G THRAP3 HSPG2 CRYBG2 TLE3 CTNND2 PHLDB2 | 8.94e-04 | 495 | 243 | 12 | EFO_0004462 |
| Disease | impulse control disorder | 9.91e-04 | 6 | 243 | 2 | MONDO_0001162 | |
| Disease | BRICHOS domain-containing protein 5 measurement | 9.91e-04 | 6 | 243 | 2 | EFO_0801430 | |
| Disease | renal overload-type gout | 9.91e-04 | 6 | 243 | 2 | EFO_0021525 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KDM3A DAB1 BCL11A DCC ARID1B ATXN2 IQCJ-SCHIP1 HERC1 TET3 MAML3 PRRC2B CPSF6 RUNX1T1 DENND1A ZFHX3 IGSF9B | 1.06e-03 | 801 | 243 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | atrial fibrillation | 1.08e-03 | 371 | 243 | 10 | EFO_0000275 | |
| Disease | Squamous cell carcinoma of esophagus | 1.15e-03 | 95 | 243 | 5 | C0279626 | |
| Disease | stroke | 1.27e-03 | 144 | 243 | 6 | EFO_0000712 | |
| Disease | irritable bowel syndrome symptom measurement | 1.34e-03 | 58 | 243 | 4 | EFO_0021536 | |
| Disease | eosinophil count | RAPGEF6 PATZ1 GATA1 KLF3 SPATA2 GGT5 ATXN2 SUPT5H IQCJ-SCHIP1 IL17RA ZC3H7B TET3 SCHIP1 ZNF577 ECE1 TLE3 NUP133 SMARCA4 CD300LG AKAP13 ASB2 TNFRSF1B MBD5 TOX2 | 1.36e-03 | 1488 | 243 | 24 | EFO_0004842 |
| Disease | chronic mucus hypersecretion | 1.38e-03 | 7 | 243 | 2 | EFO_0005673 | |
| Disease | vitamin k-dependent protein S measurement | 1.38e-03 | 7 | 243 | 2 | EFO_0020850 | |
| Disease | eye measurement | 1.39e-03 | 27 | 243 | 3 | EFO_0004731 | |
| Disease | corpus callosum central volume measurement | 1.55e-03 | 28 | 243 | 3 | EFO_0010296 | |
| Disease | disease progression measurement | 1.62e-03 | 61 | 243 | 4 | EFO_0008336 | |
| Disease | eosinophil cationic protein measurement | 1.83e-03 | 8 | 243 | 2 | EFO_0010913 | |
| Disease | Autistic behavior | 1.83e-03 | 8 | 243 | 2 | C0856975 | |
| Disease | tumor necrosis factor receptor II measurement | 1.83e-03 | 8 | 243 | 2 | EFO_0008384 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.90e-03 | 30 | 243 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | apolipoprotein A 1 measurement | LILRB2 ARID1A MUC17 ATXN2 AFF1 RIPOR1 HERC1 MGAM ZNF577 CD248 AKNA PUM2 CREB3L1 YLPM1 CD300LG TCF7L1 | 1.90e-03 | 848 | 243 | 16 | EFO_0004614 |
| Disease | Hirschsprung Disease | 2.09e-03 | 31 | 243 | 3 | C0019569 | |
| Disease | breast carcinoma (is_marker_for) | 2.17e-03 | 66 | 243 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Colorectal Carcinoma | DCC ARID1A ACSL4 KMT2C NID1 ANK2 CD248 RUNX1T1 TRIM28 TP63 TENM1 CTNND2 SPAG17 EP300 | 2.19e-03 | 702 | 243 | 14 | C0009402 |
| Disease | transmembrane protein 9 measurement | 2.34e-03 | 9 | 243 | 2 | EFO_0803190 | |
| Disease | underweight body mass index status | 2.34e-03 | 9 | 243 | 2 | EFO_0005936 | |
| Disease | Abnormality of the face | 2.34e-03 | 9 | 243 | 2 | C4025871 | |
| Disease | body fat percentage | RALGAPA1 KLF3 OPTC ACAN MAML3 PRRC2B POM121C PACS1 YLPM1 ZFHX3 IGSF9B | 2.55e-03 | 488 | 243 | 11 | EFO_0007800 |
| Disease | red blood cell density measurement | RALGAPA1 IRF2BP2 RBBP8NL WWC2 ARID1B PNPLA1 ATXN2 AFF1 PRKAG2 EP400 RFX7 TRIM33 TLE3 AKAP13 VPS13B PROX1 | 2.74e-03 | 880 | 243 | 16 | EFO_0007978 |
| Disease | pulse pressure measurement | SYNPO2L SRCAP LARP4 GJA1 ARID1B IQCJ-SCHIP1 ROBO3 PRKAG2 ARMH3 BAG6 MAP4K2 CEP97 NPAS2 ANK2 COL27A1 KIAA1217 AKAP13 ZFHX3 DOT1L CTNND2 MBD5 TCF7L1 | 2.75e-03 | 1392 | 243 | 22 | EFO_0005763 |
| Disease | Carcinoma, Granular Cell | 2.78e-03 | 116 | 243 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.78e-03 | 116 | 243 | 5 | C0205645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RASPLPPSTAPMAVS | 101 | Q8NBF4 | |
| GIPPSRPTPSDMAIV | 261 | O60488 | |
| GPPPTLSFAAPMDIT | 51 | P04003 | |
| IETPVPMPSPLSSSG | 396 | Q9P2B4 | |
| PMPSPLSSSGSSLSP | 401 | Q9P2B4 | |
| PSLGPMPTAAQPSTT | 551 | Q09472 | |
| FGMTSPPPPTSPSRT | 311 | Q96L91 | |
| SSPMSAPVRPKTSPG | 86 | Q9UGJ0 | |
| LVQMPPTPPSSHGSD | 201 | Q96BA8 | |
| PLTPMEDALPPSLSG | 576 | Q8WY36 | |
| SSTPTGEPGPMASSP | 2191 | Q6UVK1 | |
| GMAPPPAPATASASA | 561 | P46379 | |
| TAPPESSPARAPMGL | 71 | Q96Q27 | |
| PMSLSQPCLPVPSVG | 146 | Q13202 | |
| SPTEPMPPRGSLTGV | 736 | Q9HCU0 | |
| LLTMASGSPPTQPSP | 41 | O60888 | |
| MLGPGPPAPSVDSLS | 91 | P49640 | |
| MPSVSPAGPSAGAVP | 1 | Q99678 | |
| MAGSEPRSGTNSPPP | 1 | Q9UKT5 | |
| ARPTMPPPQVSGSRS | 571 | Q9Y3L3 | |
| PSAPIASSPAIDMPP | 306 | Q8IZP9 | |
| APVPTPVLAPMPAST | 331 | Q5H9F3 | |
| TPAPTPMPAATPAAI | 391 | Q5H9F3 | |
| PMPAATPAAIPTSAP | 396 | Q5H9F3 | |
| STFPPGESLPMGSTP | 1301 | Q12802 | |
| MDFPTISRSPSGPPA | 1 | O96018 | |
| TPPPASTAAGMPSLQ | 856 | Q92793 | |
| PSPVSMSPAGFPSVA | 1911 | Q92793 | |
| MSSAPAPGPAPASLT | 1 | P53672 | |
| GEGLEATTPMPSPSP | 766 | Q99490 | |
| PEMGLVTTPVSPAPT | 321 | Q5T2E6 | |
| SGPISPASIPGSQMP | 821 | Q8NFD5 | |
| SPSVPGSMKLSPQDP | 816 | Q8TEK3 | |
| TPLPGATPMKPGSAT | 476 | Q9NR19 | |
| PEPGTSQPMPLSKST | 636 | Q9HBB8 | |
| VSPGPATSPPMSPCS | 176 | Q9Y2E6 | |
| PLGAMPVPDQPSSAS | 11 | Q9UQB3 | |
| TLPHIPGSTPPMTVF | 61 | Q96JC9 | |
| MGSAKSVPVTPARPP | 1 | Q99618 | |
| TPMKTSSGDPPSPLV | 76 | Q99618 | |
| GPPPSSGMSSRVNLP | 106 | Q9NTZ6 | |
| TSFPPAPTSGMSHPP | 101 | P54725 | |
| PTADPMGLSPGVTCP | 236 | A0A5F9ZHS7 | |
| TMPAQPGTPPLSSTQ | 556 | P98160 | |
| PASGPSVPTGRAMPS | 6 | Q01201 | |
| MPSSLPGSQVPHPTL | 1 | Q8N130 | |
| SSSPSPIGMPLPSQT | 616 | Q8TB72 | |
| SSPLPSPAGMLEPLV | 641 | Q12851 | |
| GLSQAATMPAPLPSP | 456 | Q99743 | |
| MPTSPGTVSCPRAPL | 1946 | Q96PE2 | |
| ASTPHSQIPPLPGMS | 1166 | O14497 | |
| PPSPLPSSMDSNSSP | 2691 | Q01484 | |
| MGTRSSPEEGTPPPL | 1 | Q6NSJ2 | |
| LSSSMTTNDLPPPPP | 531 | Q86T65 | |
| APMSSAAAVGSLLPP | 891 | Q92585 | |
| PSSSPSPTTAGPLLM | 12216 | Q8WXI7 | |
| SASIHSMPTGTIPPP | 1866 | Q6W4X9 | |
| MFPAAPSPRTPGTGS | 1 | Q8WUM0 | |
| SVPDLSTPMLPPVGV | 836 | P43146 | |
| SPLGSSTPMASPDLL | 726 | Q96F46 | |
| ASPGLSMPSSSPPIK | 91 | P57682 | |
| EPSTALMTTAPPPGH | 681 | O60309 | |
| PPPGPSSQAATVAGM | 51 | Q9H2Z4 | |
| VFSPGSSNSRPPSPM | 1881 | Q8NEZ4 | |
| VPMAPAPASPGSSND | 751 | Q66K74 | |
| PPQSPQGASSLPTTM | 61 | P43357 | |
| PPQSPQGASSLPTTM | 61 | P43360 | |
| SAPAPAPVPTPAMVS | 441 | Q14244 | |
| SMSPGPTIPSPARAY | 26 | Q8N5M1 | |
| TSVPPMNPATTLPGL | 291 | Q9H8Y8 | |
| EPSTALMTTAPPPGH | 681 | A6NM11 | |
| EPSTALMTTAPPPGH | 681 | A6NMS7 | |
| PRTTGPMQSSVPPGS | 701 | Q96JK9 | |
| TPNSGAGSPMDTPPA | 571 | Q06455 | |
| AGSPMDTPPAATPRS | 576 | Q06455 | |
| PMNSGSISSPLPELP | 416 | Q8WWW8 | |
| AMPIPAASPTPASPA | 721 | Q99700 | |
| AGLAPTPPSMTPASN | 1196 | Q99700 | |
| VPLNIPSMPSSTPEG | 1066 | O43451 | |
| TVPASESPGVMPLSL | 2666 | Q15751 | |
| TSSPPLSPGRPSPMQ | 326 | Q9H165 | |
| MSPKGPPLVSNTAPE | 156 | Q12766 | |
| GPKASPMPVPTESSS | 1131 | Q9Y6V0 | |
| SNPTPPASVMGSPPS | 596 | Q9H6A9 | |
| APGPSSLVPTLSMIA | 421 | P98177 | |
| TAPGTPSSNPTMTRP | 96 | Q9UBM4 | |
| LGPLGIPTPTMTLAS | 2446 | O15018 | |
| TRPGMTPPCLSTVAP | 911 | P14543 | |
| MPVHTLSPGAPSAPA | 1 | Q9BQ89 | |
| ISQVSPERGMPPPSS | 261 | P42356 | |
| QPLASSTPLSLSGMP | 356 | Q8N8W4 | |
| STPLSLSGMPPVSFP | 361 | Q8N8W4 | |
| LVVSGPSMGSSPPPT | 416 | Q8N423 | |
| PSMGSSPPPTGPIST | 421 | Q8N423 | |
| AAPDPPAPLMDTGST | 646 | O75074 | |
| GMTSPPPPTSPSRTA | 301 | Q6ZTU2 | |
| SPEPSLPGPLHSMSA | 356 | P48742 | |
| PTPSENSMPPGLSTP | 771 | Q8TDZ2 | |
| LMSLGLSDPTPPSGP | 361 | Q9UJY5 | |
| RMGPSSSPIPSPSPS | 316 | P05129 | |
| SRSPAPSSGMPSSPV | 401 | Q96N21 | |
| PPSSPSMSSALAIVG | 796 | Q6VY07 | |
| PMHPVTTAPSTAPLA | 56 | P16112 | |
| GSPQVSGPSPAARMP | 1111 | O60244 | |
| SFSSSPGPVGMPLPS | 736 | Q14671 | |
| KMFVSSSGLPPSPVP | 126 | Q7Z309 | |
| VFSSMGPPASVPLPA | 751 | A8CG34 | |
| PMVAGPLSPQLLTSP | 236 | Q9HBE1 | |
| PSLMTGRSAPPSPAL | 1121 | Q9UQ26 | |
| INGAHSSPPMLSPSP | 1131 | Q96JP2 | |
| APLTTNSGLMPPSVA | 1681 | Q14686 | |
| SSMGPPASVPLPAPF | 776 | Q96HA1 | |
| PTQALPPPLSMPSTS | 521 | Q9H3D4 | |
| ASTPMDPSRPLPGSQ | 506 | Q8NC74 | |
| TGPMPPTTSTTVVAP | 396 | P15976 | |
| VMSGISSVPTPSPLG | 351 | Q8NEV1 | |
| PAASSQSALMPPAPT | 1061 | Q8TES7 | |
| SGVMAPPSGPTVAPL | 301 | P22460 | |
| PAGSMKPACPASTSP | 806 | Q9Y4C1 | |
| TNSGMPTSDSRGPPP | 366 | Q16630 | |
| SPAMPGPVSSTLGAL | 761 | Q96AV8 | |
| LFGDMSTPPDITSPP | 281 | O75553 | |
| PAMSPGPLDALSSPT | 581 | O14523 | |
| RLMLPPPSTPALSGA | 531 | O43497 | |
| MATPAVPVSAPPATP | 1 | O00303 | |
| PSSPPLAAASSMSLP | 516 | Q9BQW3 | |
| MPVASGLSPLSPTVE | 406 | Q8IW35 | |
| PVGTPDIPLGTAPSM | 1296 | O00512 | |
| APPAGSMTPKSPSTD | 201 | Q9UBP9 | |
| APTMSLQVIGPPSPG | 1581 | Q8N1P7 | |
| CSSPTAPLSPMSPPG | 271 | P17302 | |
| PPVPGPSAALTTMQL | 236 | Q9NVF7 | |
| SSSSAPPANPPSGLM | 1051 | Q86UU0 | |
| PSGLMNPSLPFTSSP | 1061 | Q86UU0 | |
| PVPGERSPSSMVPSI | 461 | P36269 | |
| IMESSPGSSPPNLTP | 801 | P00519 | |
| PAPSGQAPMPAIKTS | 691 | Q7Z591 | |
| PMDGDSPSPGSSSPL | 396 | Q02410 | |
| TRPPATMVPPTSGTS | 501 | Q8IZC6 | |
| PPLTINPSPAAMGVA | 111 | Q13495 | |
| ASNFPPLPGSSSRMP | 481 | Q71RC2 | |
| APPVTPSKPMAGTTD | 581 | Q3KQU3 | |
| TPLSPPSVMLHGSPV | 271 | Q9P267 | |
| PSMPAAPPTLPLVST | 836 | Q8TEH3 | |
| PPPVSALLSALGMST | 6 | P42892 | |
| PPMPVTGAVLPSGNT | 516 | Q5TBA9 | |
| TPGAPALTSMTPTAV | 576 | P54198 | |
| MSETAPLAPTIPAPA | 1 | P16402 | |
| SPLTSHPAAPTLMPA | 31 | Q92826 | |
| PSPMPSSTPSPSLNL | 26 | O95810 | |
| APMSISVPPLALSPG | 1656 | D6RIA3 | |
| VPSPSMDAPSPTGSE | 321 | Q5VT52 | |
| APGPSVSLSPMPPSE | 136 | Q9BWG6 | |
| VGPSTLSPGMTPLLA | 846 | Q9UJQ4 | |
| ALPTMIPAASSTPPG | 31 | Q9Y2W3 | |
| PTLVPLMNGSATPLP | 186 | Q7Z5L9 | |
| TMPGPSLESPVSTPA | 181 | Q86X76 | |
| SPAVPTPPSMSAALP | 866 | Q5VV67 | |
| TPPSMSAALPFPAGG | 871 | Q5VV67 | |
| SLPLSMGPVLPDPFT | 901 | Q5VV67 | |
| DPSMSPLGVATLTPS | 1491 | Q12756 | |
| PTSPPSEGTTPLASM | 1151 | Q685J3 | |
| PPTAEVTSMPTSTPG | 1201 | Q685J3 | |
| ASSPPPTAEGTSMPT | 2316 | Q685J3 | |
| IRSGSAPPATPVMVP | 266 | Q9UBD0 | |
| HLDNLPSSPTSPMPG | 346 | Q9P2F6 | |
| PSSPTSPMPGQLFGI | 351 | Q9P2F6 | |
| VPNSGALSPPLMPAS | 81 | Q8NET4 | |
| SPLLMPASDSGALSP | 101 | Q8NET4 | |
| SAEISPLAMPAPSSG | 161 | Q8NET4 | |
| PLAMPAPSSGVVCTP | 166 | Q8NET4 | |
| TELGIMEPSSPNPSP | 491 | Q5VT97 | |
| EPPAPPSAAAMTSTA | 566 | Q9H987 | |
| TTMAPRPATPTSAPP | 486 | O00268 | |
| PQATSGLMEPPGPST | 71 | O14994 | |
| VAPPLPMGASVPSID | 771 | Q6WKZ4 | |
| TMNPSPGPSALSPGS | 716 | Q9UPN9 | |
| LAIMPIPGTLSSSSP | 716 | Q8TEU7 | |
| PGTPIMPSPADSTNS | 276 | Q9BWW4 | |
| LASTPPPGPMTTSVS | 171 | B4DYI2 | |
| MNSSPAGTPSPQPSR | 1 | Q9HBY8 | |
| QPTVIPSGPAGSMPL | 401 | Q9UMZ2 | |
| HPQDLASTPSPGPMT | 161 | Q5VVP1 | |
| GRSATTAMPPPVPNG | 136 | P0DPB3 | |
| SPAPPAPMQSISSGI | 336 | Q6ZMB5 | |
| GQAPFSPSASLPMSP | 1031 | Q9H6K5 | |
| SPSASLPMSPLATPP | 1036 | Q9H6K5 | |
| SPPECLSPFGRPTMS | 136 | Q92786 | |
| HPQDLASTPSPGPMT | 161 | Q8IWB4 | |
| SPPPNVTASPSMDGL | 1281 | Q9Y6Q9 | |
| SSPVPASGPSSGPQM | 131 | P51532 | |
| STPVPHSMPPSPSRI | 316 | Q5T5P2 | |
| ATMPVVPSVASLAPP | 306 | Q9NR46 | |
| MTTRSQPSPAAPAPP | 221 | Q9UKZ4 | |
| VMGSSIPSPSPPDPA | 496 | O60285 | |
| ASPSPSPVGYSPMTP | 941 | O00267 | |
| MPPSSAPPSNSGAGI | 986 | Q9UHV7 | |
| GGRSATTAMPPPVPN | 211 | B3KU38 | |
| DLASTPPPGPMTTSV | 176 | P0DKV0 | |
| PPPGPMTTSVSSLSA | 181 | P0DKV0 | |
| PASLMVSASPAGPPL | 1046 | Q6ZRS2 | |
| PTLGTARAPMPTPTL | 1356 | Q6ZRS2 | |
| LHVPSSLPGPASSPM | 1401 | Q6ZRS2 | |
| SLPGPASSPMPIPNS | 1406 | Q6ZRS2 | |
| PSVRSMSGPESSPPI | 2791 | Q6ZRS2 | |
| PPISRSGAASMPSSP | 191 | Q86SQ0 | |
| LGNTPTMPFSSLPPT | 511 | Q13546 | |
| FGSSAVALPTPMPTP | 801 | Q96KW2 | |
| SAMGPAPLISTPPSR | 456 | Q01826 | |
| AAAMEPPPSSPTLSA | 31 | O94993 | |
| NSGLICPPSEMPATP | 1316 | Q6Q759 | |
| PPPLGSPFPVISSSM | 126 | P28702 | |
| IAVMTPTVPGSPKAP | 821 | Q9UPX8 | |
| ASTGTPSPLSPMPSP | 1096 | P51825 | |
| PSPLSPMPSPASSVG | 1101 | P51825 | |
| ATSPPAGSSRPPMQL | 206 | Q6UXG3 | |
| PAPTSPFPSATAGSM | 1146 | Q96RK0 | |
| ERGMFSSPSPPPALL | 21 | Q96KN2 | |
| GMASPGLAAPSLTPP | 126 | Q9ULV3 | |
| TPTTGVPTMSLHTPP | 111 | Q9NZN8 | |
| VPTMSLHTPPSPSRG | 116 | Q9NZN8 | |
| MSASAGPKPPPATTG | 116 | Q15735 | |
| VMPASAGPRSPPVTL | 141 | Q15735 | |
| HPQDLASTPSPGPMT | 161 | Q5VYP0 | |
| PKMPPRTPAEASSTG | 236 | Q9Y676 | |
| NGTGVSMEPSPPTPS | 511 | Q86XZ4 | |
| MASPSPPPESKGLLT | 1 | O75820 | |
| RVLPMVPAPPGSSAA | 126 | Q6ZTA4 | |
| MASSPHGSPDVLPPA | 301 | Q9UM82 | |
| TPRSDMPTPGTSATP | 321 | Q04724 | |
| PISAPMIVSALPPGS | 141 | Q8TF68 | |
| PKPSPPLSSTSQMGS | 271 | Q9Y2W1 | |
| SPPGSPLVLEGTFPM | 556 | Q6AWC2 | |
| LKAPPATTPASMPLG | 2201 | Q9C0A1 | |
| ATTPASMPLGAAPTL | 2206 | Q9C0A1 | |
| PPPVSGLSEPTSFML | 1616 | Q6GYQ0 | |
| QSPTMSPLASPPSSP | 186 | Q8NFH8 | |
| HPQDLASTPSPGPMT | 161 | Q5TZJ5 | |
| HPQDLASTPSPGPMT | 161 | Q5VU36 | |
| LPLGSMPTALLASPP | 546 | Q9HCS4 | |
| DMPGSEIPPSSPSHA | 886 | Q12767 | |
| PEVGSPLSSVMSSPP | 986 | Q9UPX0 | |
| PLSSVMSSPPLPTEG | 991 | Q9UPX0 | |
| PSSLGMTPAPVPTSL | 1141 | Q9H7N4 | |
| SASDMVTPGSLSPPP | 6 | Q8N431 | |
| PGTPIMPSPGDSTNS | 271 | Q9BWG4 | |
| PLGPSSPLSVSQPML | 1181 | Q96MS0 | |
| NTVPIEMPSSGTPPL | 411 | Q9BSK1 | |
| PPTIPTMIAAASPPS | 721 | Q9H0E3 | |
| MEGTSPSSPPPSGVR | 956 | Q9HBL0 | |
| ASPTGSPPRASPMTP | 246 | Q9UF83 | |
| PGTPTSEPAPTPSMT | 346 | Q9H8N7 | |
| SEPAPTPSMTGLPLS | 351 | Q9H8N7 | |
| PLAPTMAPAPAAPST | 441 | Q7Z410 | |
| PTLNTPAPVAMPASP | 441 | Q9P1Z0 | |
| SVAPSASMPGSHLPP | 1911 | Q5JSZ5 | |
| NTLPSPPPAAAASPM | 166 | Q96G79 | |
| PTPTPTPTSEMIAGS | 861 | Q2KHR2 | |
| PSPMTALQPGSTGPL | 686 | O43151 | |
| TSTTPGLRSMPGKPP | 331 | Q04726 | |
| TSVPPPGMPPSLSSA | 571 | P49750 | |
| SGPSVPSVPMVSPLP | 456 | Q9UBD6 | |
| CASLTLGPPTPPASM | 401 | Q8IZN3 | |
| APTQMSTVPSGLPLP | 56 | Q86TA4 | |
| SRTKMTGSAPPPSPT | 826 | Q9UBW7 | |
| ATGLPTVPSVPAMPG | 151 | P31314 | |
| TSPETMAGPVPTSPV | 1251 | Q7Z7G8 | |
| GALLSPPVSMSPAPQ | 396 | Q96NM4 | |
| ACSPSLLPTLSAPMP | 406 | Q70CQ3 | |
| FLLPMGPSPPAEGST | 241 | P20333 | |
| PPTTTSPTPSGMGLV | 641 | Q6ZS17 | |
| PPPGIVAPAAMLSSR | 1171 | Q96J92 | |
| MTVSGPGTPEPRPAT | 1 | Q9H3U1 | |
| MEPSPLSPSGAALPL | 1 | O15209 | |
| GALSSPPPTVMVPVG | 796 | O95405 | |
| PAPNLGPMSGPLSVS | 186 | P0DV77 | |
| SAVLVEPPPMSLPGA | 806 | Q13263 | |
| GLDPDPSLPTPDMSS | 51 | Q9H0D2 | |
| LMGLPSTTVPSPGLP | 3151 | Q15911 | |
| TSVVMLTPNPDGPPS | 61 | Q6UXF1 | |
| GSPALLPSTPTMPLF | 216 | Q9UGR2 | |
| PVSSPLPPASFGLVM | 311 | Q9UGR2 | |
| PLSPSGEPSLSPQLM | 916 | O14686 | |
| LEPSATSPLPSPMGD | 1086 | O14686 | |
| TSPLPSPMGDLSCPA | 1091 | O14686 | |
| SPTGAPAQPPMLGAS | 2201 | O14686 | |
| PMSSGPISNIEPTSP | 466 | E9PAV3 | |
| MAPGAPSSSPSPILA | 1 | P25189 |